≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Generalized epilepsy

DOID EFO Endpoint Browser PheWeb

GE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — G40.3
  • Hospital discharge: ICD-9 — 345[0-3]
  • Hospital discharge: ICD-8 — 34519
  • Hospital discharge: excluded ICD-8 — 34511
  • Cause of death: ICD-10 — G40.3
  • Cause of death: ICD-9 — 345[0-3]
  • Cause of death: ICD-8 — 34519
  • Cause of death: excluded ICD-8 — 34511

2 out of 7 registries used, show all original rules.

1795

4. Check minimum number of events

None

1795

5. Include endpoints

None

1795

6. Filter based on genotype QC (FinnGen only)

1720

Control definitions (FinnGen only)

Control exclude
G6_EPLEPSY

Extra metadata

First used in FinnGen datafreeze
DF3

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 23791 11883 11645
Only index persons 18264 9848 8416
Unadjusted period prevalence (%)
Whole population 0.33 0.34 0.33
Only index persons 0.34 0.36 0.32
Median age at first event (years)
Whole population 27.14 24.77 28.84
Only index persons 22.12 22.16 22.08

-FinnGen-

Key figures

All Female Male
Number of individuals 1720 1039 681
Unadjusted period prevalence (%) 0.35 0.37 0.31
Median age at first event (years) 27.45 24.49 31.95

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1795
Matched controls
17950
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
183
Kela drug reimbursment
Lamotrigin and topiramate
+∞
307.7
504
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
+∞
307.7
375
*
N05BA01
ATC
diazepam; systemic, rectal
8.3
307.7
612
1059
G40.30
ICD-10 Finland
Benign myoclonic eplilepsy in infancy
+∞
307.7
321
*
N03AG01
ATC
valproic acid; systemic, rectal
62.5
307.7
1050
396
N03AF01
ATC
carbamazepine; oral, rectal
35.1
307.7
580
241
N03AX09
ATC
lamotrigine; oral
15.8
307.7
549
488
G40.9
ICD-10 Finland
Epilepsy, unspecified
4654.5
307.7
999
5
N03AB02
ATC
phenytoin; systemic
121.8
307.7
176
16
3451A
ICD-9 Finland
Epilepsy, Generalised convulsive epilepsy
+∞
307.7
380
*
G40.3
ICD-10 Finland
Generalized idiopathic epilepsy and epileptic syndromes
+∞
307.7
353
*
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
+∞
307.7
866
*
N03AX14
ATC
levetiracetam; systemic
216.5
307.7
565
38
N03AF02
ATC
oxcarbazepine; oral
83.1
307.7
491
81
R56.8
ICD-10 Finland
Other and unspecified convulsions
34.8
307.7
611
262
G40
ICD-10 Finland
Epilepsy
1989.0
307.7
319
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
7949.6
307.7
566
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
307.7
1588
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
307.7
360
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
+∞
306.3
285
*
N88
ICPC
Epilepsy
+∞
252.2
236
*
N05BA09
ATC
clobazam; oral
426.4
230.1
226
6
N03AE01
ATC
clonazepam; systemic
9.3
222.3
292
368
7803A
ICD-9 Finland
General symptoms, Convulsions
24.3
215.8
156
70
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
213.9
201
*
G40.36
ICD-10 Finland
Juvenile myoclonic epilepsy [impulsive petit mal]
+∞
209.6
197
*
N03AX11
ATC
topiramate; oral
11.4
192.0
211
208
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
+∞
191.1
180
*
N05CD08
ATC
midazolam; nasal, systemic
18.3
183.2
150
89
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
12.7
180.8
183
159
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
+∞
163.0
154
*
G40.89
ICD-10 Finland
Other epilepsy
+∞
159.8
151
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
+∞
144.8
137
*
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
19.8
143.1
112
60
G40.10
ICD-10 Finland
Simple partial seizures
+∞
140.5
133
*
3459X
ICD-9 Finland
Epilepsy, unspecified
+∞
137.3
130
*
N03AX18
ATC
lacosamide; systemic
715.8
136.6
133
*
34599
ICD-8 Finland
Epilepsy, Other and unspecified
+∞
125.5
119
*
34519
ICD-8 Finland
Epilepsy, Generalisata convulsiva NUD
+∞
125.5
119
*
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
+∞
115.9
110
*
AA1AD
NOMESCO Finland
CT of head and brain
3.1
97.9
578
2416
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
990.0
96.9
94
*
XA800
NOMESCO Finland
Neuropsychological investigation
5.8
96.5
190
362
G40.35
ICD-10 Finland
Juvenile absence epilepsy
+∞
95.7
91
*
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
+∞
94.6
90
*
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
+∞
93.6
89
*
34510
ICD-8 Finland
Epilepsy, """"Grand mal""""
+∞
92.5
88
*
3453A
ICD-9 Finland
Epilepsy, Grand mal status
+∞
90.4
86
*
3450A
ICD-9 Finland
Epilepsy, Generalised nonconvulsive epilepsy
+∞
90.4
86
*
N03AX22
ATC
perampanel; oral
+∞
85.1
81
*
G40.33
ICD-10 Finland
Juvenile absence epilepsy
+∞
85.1
81
*
N03AD01
ATC
ethosuximide; oral
+∞
85.1
81
*
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
+∞
84.0
80
*
XA400
NOMESCO Finland
EEG
29.8
82.7
55
19
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
+∞
81.9
78
*
N03AX23
ATC
brivaracetam; systemic
+∞
80.8
77
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
127.4
79.6
85
7
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
8.4
74.3
99
124
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.7
72.3
252
751
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.6
62.8
228
696
N03AX15
ATC
zonisamide; oral
89.7
62.4
69
8
N03AG04
ATC
vigabatrin; oral
+∞
61.8
59
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.3
60.7
262
891
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
10.0
54.7
63
65
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
5.4
52.2
106
206
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
9.2
51.3
63
71
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.6
48.9
169
497
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.3
47.9
199
658
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
46.2
283
1161
181
Kela drug reimbursment
Retigabine and vigabatrin
+∞
45.0
43
*
3454B
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[TEMPORAALIEPILEPTINEN POISSAOLOKOHTAUS]
+∞
42.9
41
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.5
41.6
303
1348
N05AX08
ATC
risperidone; systemic
3.0
41.4
204
743
R56.0
ICD-10 Finland
Febrile convulsions
10.7
40.3
44
42
N05AA02
ATC
levomepromazine; systemic
4.2
40.2
110
273
R55
ICD-10 Finland
Syncope and collapse
2.8
40.1
220
849
Z2445
NOMESCO Finland
Psychologist
3.4
39.7
150
466
34532
ICD-8 Finland
Epilepsy, Partialis (focalis) generalisata
+∞
38.7
37
*
G40.0
ICD-10 Finland
Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset
+∞
38.7
37
*
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
+∞
37.6
36
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
36.9
309
1458
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
+∞
36.6
35
*
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
36.6
35
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.0
36.4
175
627
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
35.7
451
2505
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.0
34.8
165
587
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
34.6
543
3254
N05AD01
ATC
haloperidol; systemic
4.8
34.1
78
168
G41.0
ICD-10 Finland
Grand mal status epilepticus
77.7
33.9
38
5
N03AF04
ATC
eslicarbazepine; oral
+∞
31.3
30
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
30.9
276
1332
N05AH03
ATC
olanzapine; systemic
2.7
30.0
171
670
34530
ICD-8 Finland
Epilepsy, Psychomotorica
+∞
29.2
28
*
34500
ICD-8 Finland
Epilepsy, """"Petit mal""""
+∞
28.2
27
*
N06AB04
ATC
citalopram; systemic
2.0
27.0
369
2084
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
26.6
382
2193
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
26.4
265
1337
N07
ICPC
Convulsion/seizure
37.3
26.2
33
9
R42
ICD-10 Finland
Dizziness and giddiness
1.9
26.2
378
2174
G40.7
ICD-10 Finland
Petit mal, unspecified, without grand mal seizures
+∞
26.1
25
*
W19
ICD-10 Finland
Unspecified fall
2.3
25.7
206
947
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.6
25.6
49
90
A06AD11
ATC
lactulose; oral
2.3
25.4
219
1038
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
25.1
159
656
F44.5
ICD-10 Finland
Dissociative convulsions
+∞
25.1
24
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
24.9
415
2497
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.9
24.6
118
421
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.4
24.2
177
780
N05AH04
ATC
quetiapine; oral
1.9
24.1
376
2211
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.9
23.8
112
396
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
23.8
312
1732
N05CD07
ATC
temazepam; oral
2.4
23.6
170
744
N05AH02
ATC
clozapine; systemic
4.2
23.3
63
155
R40.2
ICD-10 Finland
Coma, unspecified
9.8
23.3
27
28
G40.80
ICD-10 Finland
Epilepsy with continuous EEG spike-waves during slow wave sleep
+∞
23.0
22
*
G40.34
ICD-10 Finland
Epilepsy with grand mal seizures on awakening
+∞
23.0
22
*
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
9.1
22.1
27
30
Z2446
NOMESCO Finland
Social worker
2.4
22.0
164
728
G40.8
ICD-10 Finland
Other epilepsy
+∞
21.9
21
*
34598
ICD-8 Finland
Epilepsy, Alia definita
+∞
21.9
21
*
F20.9
ICD-10 Finland
Schizophrenia, unspecified
3.9
21.7
64
168
S06.0
ICD-10 Finland
Concussion
2.1
21.5
232
1197
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
6.6
21.3
34
52
N03AG06
ATC
tiagabine; oral
+∞
20.9
20
*
G40.59
ICD-10 Finland
Other special epileptic syndromes
+∞
20.9
20
*
G40.31
ICD-10 Finland
Benign neonatal convulsions (familial)
+∞
20.9
20
*
3454X
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[ALII DISTURBATIONES CONSCIENTAE EPILEPTICI]
+∞
20.9
20
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
7.4
20.8
30
41
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.1
20.6
90
305
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
42.2
20.5
25
6
R11
ICD-10 Finland
Nausea and vomiting
2.2
20.4
192
940
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
20.3
701
5102
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.7
20.1
46
99
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3.9
19.9
58
151
3069, ,
Kela drug reimbursment
+∞
19.8
19
*
N05CD02
ATC
nitrazepam; oral
5.3
19.4
39
75
N03AA02
ATC
phenobarbital; systemic
55.6
18.9
22
*
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
3.8
18.9
57
152
WX892
NOMESCO Finland
Monitored bed care
2.4
18.8
137
602
1541, ,
Kela drug reimbursment
+∞
18.8
18
*
N04AA02
ATC
biperiden; systemic
4.2
18.7
49
118
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
18.6
359
2235
G41.2
ICD-10 Finland
Complex partial status epilepticus
191.9
18.6
19
*
N05AF03
ATC
chlorprothixene; systemic
3.6
18.5
62
178
A28
ICPC
Limited function/disability NOS
2.0
18.5
225
1211
R53
ICD-10 Finland
Malaise and fatigue
1.7
18.0
470
3173
N05AB03
ATC
perphenazine; systemic, rectal
3.1
17.8
77
259
N03AX25
ATC
cenobamate; oral
+∞
17.7
17
*
G40.37
ICD-10 Finland
Baltic myoclonus
+∞
17.7
17
*
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
37.1
17.6
22
6
C03CA01
ATC
furosemide; systemic
1.7
17.5
337
2095
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.6
17.4
101
399
TAB00
NOMESCO Finland
Lumbar puncture
2.6
17.3
99
388
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.4
17.3
128
567
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
50.5
17.0
20
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
17.0
159
776
N05BA04
ATC
oxazepam; oral
1.6
16.7
432
2899
3452A
ICD-9 Finland
Epilepsy, Petit mal status
+∞
16.7
16
*
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
18.1
16.5
25
14
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
5.8
15.9
29
51
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.1
15.8
67
223
Z3231
NOMESCO Finland
Registered nurse
1.6
15.8
457
3148
S01.0
ICD-10 Finland
Open wound of scalp
2.3
15.7
129
597
H53.4
ICD-10 Finland
Visual field defects
4.2
15.6
41
99
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.4
15.5
57
174
7802X
ICD-9 Finland
General symptoms, Syncope and collapse[SYNCOPE ET COLLAPSUS NUD]
13.9
15.5
26
19
N05AF05
ATC
zuclopenthixol; systemic
5.7
15.1
28
50
Y0209
ICD-8 Finland
Examination of the nervous system and sensory organs, Nervous system
11.9
15.1
27
23
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
15.0
161
827
G41.1
ICD-10 Finland
Petit mal status epilepticus
+∞
14.6
14
*
A04
ICPC
Weakness/tiredness general
1.7
14.5
299
1887
N05AC02
ATC
thioridazine; oral
3.6
14.4
47
133
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
3.5
14.3
48
138
R51.80
ICD-10 Finland
Headache
1.7
14.3
323
2086
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.1
14.2
132
642
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
14.1
192
1071
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
6.7
14.0
22
33
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
12.8
13.9
24
19
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
4.8
13.8
31
66
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.2
13.7
118
556
P99
ICPC
Psychological disorders other
2.6
13.6
79
312
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
13.6
653
4996
L28
ICPC
Limited function/disability (L)
1.8
13.6
244
1480
T90.5
ICD-10 Finland
Sequelae of intracranial injury
4.8
13.6
30
63
34539
ICD-8 Finland
Epilepsy, Partialis (focalis) NUD
+∞
13.6
13
*
4300A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]
25.9
13.4
18
7
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
11.6
13.3
24
21
N05AX12
ATC
aripiprazole; systemic
2.3
13.3
107
491
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.4
13.2
47
141
SPAT1301
SPAT
No procedures
1.5
13.2
481
3472
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.2
13.1
50
157
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.9
12.6
161
879
SPAT1229
SPAT
Assessment of need for aid
2.3
12.5
92
406
AAA35
NOMESCO Finland
Insertion of subdural electrodes
+∞
12.5
12
*
N29
ICPC
Neurological sympt/complt other
3.7
12.5
39
107
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
5.7
12.4
23
41
P72
ICPC
Schizophrenia
3.2
12.4
49
157
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
12.3
196
1147
N28
ICPC
Limited function/disability (N)
4.2
12.3
32
77
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
6.1
12.1
21
35
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
12.0
304
2014
P76
ICPC
Depressive disorder
1.9
12.0
157
863
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
3.6
11.7
38
107
F83
ICD-10 Finland
Mixed specific developmental disorders
4.1
11.7
32
80
R32
ICD-10 Finland
Unspecified urinary incontinence
3.2
11.5
44
138
P85
ICPC
Mental retardation
11.2
11.5
21
19
S42.2
ICD-10 Finland
Fracture of upper end of humerus
2.5
11.5
69
278
G40.50
ICD-10 Finland
Epilepsia partialis continua [Kozhevnikof]
+∞
11.5
11
*
3458X
ICD-9 Finland
Epilepsy, Other forms of epilepsy
+∞
11.5
11
*
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
4.4
11.5
28
64
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
11.3
160
901
RS222, ,
NOMESCO Finland
4.2
11.3
30
73
SPAT1254
SPAT
Administration of medicine
1.7
11.3
237
1495
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.9
11.3
51
177
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
35.3
11.3
14
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
11.2
365
2558
P29
ICPC
Psychological sympt/compl other
1.8
11.2
186
1100
G81.9
ICD-10 Finland
Hemiplegia, unspecified
5.0
11.2
24
49
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
11.2
399
2852
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.8
11.2
189
1124
R60.9
ICD-10 Finland
Oedema, unspecified
2.3
11.2
82
362
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
3.8
11.0
33
88
G25.0
ICD-10 Finland
Essential tremor
3.2
11.0
44
142
N05CF01
ATC
zopiclone; oral
1.5
11.0
434
3166
A46
ICD-10 Finland
Erysipelas
1.7
11.0
192
1154
R41.0
ICD-10 Finland
Disorientation, unspecified
3.2
10.9
42
133
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
5.2
10.8
22
43
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
5.2
10.8
22
43
WX730
NOMESCO Finland
Conventional respirator
4.3
10.8
27
63
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
3.2
10.7
41
129
XCK00
NOMESCO Finland
Perimetry
2.3
10.7
78
344
SPAT1240
SPAT
Therapeutic discussion
1.7
10.6
217
1359
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.9
10.6
127
678
A10AB01
ATC
insulin (human); parenteral
2.4
10.6
69
289
N01
ICPC
Headache
1.6
10.6
273
1814
ZY010
NOMESCO Finland
Hospital outpatient
2.0
10.5
123
651
79399
ICD-8 Finland
Observation, without need for further medical care, Unspecified
5.0
10.5
22
44
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.4
10.5
68
284
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
4.7
10.5
24
52
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
4.7
10.5
24
52
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.1
10.4
98
479
J01EA01
ATC
trimethoprim; systemic
1.5
10.4
375
2681
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
110.7
10.4
11
*
34520
ICD-8 Finland
Epilepsy, Status epilepticus
+∞
10.4
10
*
96698
ICD-8 Finland
Other antiepileptics
+∞
10.4
10
*
R25.2
ICD-10 Finland
Cramp and spasm
2.9
10.3
46
159
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
23.5
10.2
14
6
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
5.3
10.1
20
38
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.9
10.1
47
166
A29
ICPC
General symptom/complaint other
1.7
10.1
201
1252
ZXD05
NOMESCO Finland
Urgent procedure
1.4
10.1
480
3625
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
10.0
388
2815
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
10.0
629
4990
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.6
10.0
238
1551
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
9.9
486
3685
K07
ICPC
Swollen ankles/oedema
2.5
9.9
63
261
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.7
9.9
174
1046
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
9.8
123
2142
N06AX16
ATC
venlafaxine; oral
1.6
9.8
251
1663
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
20.1
9.8
14
7
R1250
NOMESCO Finland
Evaluation of functional capability
2.8
9.8
47
169
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.8
9.7
146
838
N18
ICPC
Paralysis/weakness
3.7
9.7
30
82
C07AA05
ATC
propranolol; systemic
1.5
9.7
342
2433
6489X
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Other current conditions classifiable elsewhere
13.4
9.7
16
12
N03AX12
ATC
[U] gabapentin; oral
1.6
9.7
221
1425
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.6
9.6
248
1645
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.0
9.6
99
501
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.3
9.6
71
315
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
4.6
9.5
22
48
F61.0
ICD-10 Finland
Mixed personality disorders
3.1
9.5
39
128
SPAT1216
SPAT
Assessment of functional ability
1.7
9.5
180
1105
SPAT1210
SPAT
Application of cast or individual aid
2.3
9.5
69
304
78259
ICD-8 Finland
Symptoms referable to cardiovascular and lymphatic system, Syncope (lipothymia) alia sive NUD
30.2
9.4
12
*
G41.8
ICD-10 Finland
Other status epilepticus
+∞
9.4
9
*
G40.51
ICD-10 Finland
Epileptic seizures related to alcohol
+∞
9.4
9
*
AAJ99
NOMESCO Finland
Other operation for epilepsy
+∞
9.4
9
*
K90
ICPC
Stroke/cerebrovascular accident
3.2
9.4
37
119
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
9.3
123
678
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.0
9.3
105
549
F20.0
ICD-10 Finland
Paranoid schizophrenia
4.9
9.3
20
41
OAB43, ,
SPAT
0.7
9.3
448
5769
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.2
9.3
80
379
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
9.3
233
1537
A10AA02, ,
ATC
2.5
9.2
55
222
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.1
9.1
38
126
H03AA01
ATC
levothyroxine sodium; systemic
1.5
9.1
329
2348
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.6
9.1
29
81
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
4.8
9.1
20
42
N91.4
ICD-10 Finland
Secondary oligomenorrhoea
4.6
9.1
21
46
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.2
9.0
77
363
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.8
9.0
127
715
SPAT1263
SPAT
Sampling
1.4
9.0
660
5348
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
8.9
153
913
M41.4
ICD-10 Finland
Neuromuscular scoliosis
18.7
8.9
13
7
R5599
NOMESCO Finland
Other rehabilitation service
2.6
8.9
52
207
2161
FHL
Neck ligation, big brain
24.1
8.9
12
5
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
24.1
8.9
12
5
S01.9
ICD-10 Finland
Open wound of head, part unspecified
3.1
8.7
35
114
F72.0
ICD-10 Finland
Severe mental retardation, with the statement of no, or minimal, impairment of behaviour
50.2
8.7
10
*
R50.9
ICD-10 Finland
Fever, unspecified
1.5
8.6
267
1844
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.6
8.6
47
181
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.0
8.6
86
431
N03AX16
ATC
[U] pregabalin
1.5
8.6
302
2142
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
8.6
122
689
S42.0
ICD-10 Finland
Fracture of clavicle
2.5
8.6
51
205
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
8.6
272
1889
N05BA06
ATC
lorazepam; systemic, sublingual
2.2
8.6
74
351
S82.6
ICD-10 Finland
Fracture of lateral malleolus
1.9
8.6
99
523
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
16.4
8.6
13
8
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.1
8.5
81
399
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
3.0
8.5
36
121
J01DA01
ATC
[U] cefalexin
1.3
8.5
952
8204
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
7.4
8.4
19
26
R4150
NOMESCO Finland
Neuropsychological rehabilitation
4.3
8.4
21
49
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.6
8.4
47
184
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
7.9
8.4
18
23
S03.20
ICD-10 Finland
Dental dislocation
4.0
8.3
23
58
N99
ICPC
Neurological disease other
4.0
8.3
23
58
V628A
ICD-9 Finland
Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified
+∞
8.3
8
*
3456B
ICD-9 Finland
Epilepsy, Infantile spasms[EPILEPSIA MYOCLONICA CUM ASTASIA]
+∞
8.3
8
*
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.4
8.3
447
3434
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
8.2
153
935
OAA67, ,
SPAT
0.6
8.2
174
2649
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
14.5
8.2
13
9
N03AA03
ATC
primidone; oral
14.5
8.2
13
9
S70.0
ICD-10 Finland
Contusion of hip
2.3
8.2
59
260
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
8.2
157
968
RS221, ,
NOMESCO Finland
3.0
8.1
35
119
Z2221
NOMESCO Finland
Medical doctor
1.4
8.1
422
3221
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.5
8.0
49
200
J46
ICD-10 Finland
Status asthmaticus
2.5
8.0
49
200
F71.1
ICD-10 Finland
Moderate mental retardation, significant impairment of behaviour requiring attention or treatment
22.1
8.0
11
5
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
6.3
8.0
20
32
J01FF01
ATC
clindamycin; systemic
1.4
8.0
387
2916
Z3226
NOMESCO Finland
Physiotherapist
1.5
7.9
266
1868
N06AB10
ATC
escitalopram; oral
1.4
7.9
373
2795
R41.3
ICD-10 Finland
Other amnesia
2.9
7.9
35
121
F99
ICD-10 Finland
Mental disorder, not otherwise specified
2.5
7.9
48
196
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
6.1
7.8
20
33
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
6.1
7.8
20
33
SPAT1050
SPAT
Extensive neurological examination
3.0
7.8
34
116
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.6
7.8
43
167
K92.0
ICD-10 Finland
Haematemesis
2.8
7.7
38
139
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
3.1
7.7
31
101
31099
ICD-8 Finland
Borderline mental retardation, Other and unspecified
45.2
7.7
9
*
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
45.2
7.7
9
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
7.7
125
735
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
15.1
7.7
12
8
N05AL01
ATC
sulpiride; systemic
3.6
7.7
25
71
F39
ICD-10 Finland
Unspecified mood [affective] disorder
2.5
7.7
45
180
N06AX11
ATC
mirtazapine; oral
1.4
7.7
511
4055
N05AB04
ATC
prochlorperazine; systemic, rectal
3.3
7.7
28
86
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
7.6
143
876
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
7.6
155
971
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
7.6
308
2245
L17
ICPC
Foot/toe symptom/complaint
1.4
7.6
462
3614
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.3
7.5
54
238
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
2.6
7.4
43
171
G43.9
ICD-10 Finland
Migraine, unspecified
1.7
7.4
133
804
S20.2
ICD-10 Finland
Contusion of thorax
1.9
7.4
85
448
R4120
NOMESCO Finland
Occupational therapy
1.9
7.4
99
549
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
4.0
7.3
20
50
WX704
NOMESCO Finland
Intubation
1.7
7.3
124
738
Z50.5
ICD-10 Finland
Speech therapy
2.8
7.3
35
126
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
7.3
290
2103
30188
ICD-8 Finland
Personality disorders, Alia definita
8.4
7.3
15
18
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
7.3
360
2716
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
10.9
7.3
13
12
N03AX17
ATC
stiripentol; oral
+∞
7.3
7
*
AAJ20
NOMESCO Finland
Excision of epileptic focus
+∞
7.3
7
*
N03AF03
ATC
rufinamide; oral
+∞
7.3
7
*
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.0
7.3
75
381
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.4
7.3
46
191
E883A
ICD-9 Finland
Fall into hole or other opening in surface
2.1
7.3
65
313
U04
ICPC
Incontinence urine
2.1
7.3
69
340
N05BA02
ATC
chlordiazepoxide; systemic
2.7
7.3
37
138
N05AD03
ATC
melperone; systemic
3.9
7.3
21
55
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.9
7.3
21
55
85000
ICD-8 Finland
Concussion, Current or unspecified
2.8
7.2
35
127
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.0
7.2
79
411
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
7.2
459
3614
2152
FHL
Extraction, big brain
20.1
7.1
10
5
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.2
7.1
57
263
Z30.0
ICD-10 Finland
General counselling and advice on contraception
1.7
7.1
133
815
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.6
7.1
38
146
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
8.8
7.0
14
16
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.4
7.0
45
188
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
4.2
7.0
18
43
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.2
7.0
27
86
IEY01
NOMESCO Finland
Psychoeducation, individual
3.2
7.0
27
86
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
7.0
7.0
16
23
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
7.0
93
516
SPAT1172
SPAT
Guidance concerning hydration
3.3
7.0
25
76
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.6
7.0
162
1048
J01DB01
ATC
cefalexin; oral
1.4
7.0
1384
12771
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.8
6.9
100
569
R60.0
ICD-10 Finland
Localized oedema
1.6
6.9
155
994
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
5.5
6.9
19
35
A10AA01, ,
ATC
2.4
6.9
46
196
N91.1
ICD-10 Finland
Secondary amenorrhoea
2.5
6.9
43
178
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.1
6.8
66
328
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
6.8
130
800
N30.0
ICD-10 Finland
Acute cystitis
1.5
6.8
257
1845
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
4.1
6.8
18
44
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
6.7
6.8
16
24
M79.6
ICD-10 Finland
Pain in limb
1.3
6.8
668
5592
43090
ICD-8 Finland
Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata
40.2
6.8
8
*
C02AC05
ATC
moxonidine; oral
2.3
6.7
51
230
N06AA09
ATC
amitriptyline; systemic
1.7
6.7
108
634
X58
ICD-10 Finland
Exposure to other specified factors
1.5
6.7
254
1824
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
3.9
6.7
19
49
F22.0
ICD-10 Finland
Delusional disorder
3.2
6.7
25
78
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
22.6
6.7
9
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
22.6
6.7
9
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.2
6.6
54
251
E8859
ICD-8 Finland
Fall on same level from slipping, stumbling or tripping
2.4
6.6
42
175
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
2.0
6.6
65
325
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.9
6.6
77
409
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
5.9
6.6
17
29
G04BD09
ATC
trospium; oral
2.9
6.6
29
100
G04BD07
ATC
tolterodine; oral
2.2
6.6
54
252
QAB00
NOMESCO Finland
Suture of skin of head or neck
3.2
6.6
25
79
S21
ICPC
Skin texture symptom/complaint
1.5
6.6
218
1526
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
6.6
177
1186
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
8.7
6.6
13
15
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
2.2
6.5
53
246
SPAT1104
SPAT
Monitoring of emergency patient
1.9
6.5
84
461
79199
ICD-8 Finland
Headache
3.8
6.5
19
50
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
10.1
6.5
12
12
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
1.9
6.5
78
418
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
6.5
200
1380
3141A
ICD-9 Finland
Hyperkinetic syndrome of childhood, Hyperkinesis with developmental delay
70.1
6.4
7
*
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
3.3
6.4
23
70
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
7.4
6.4
14
19
SPAT1251
SPAT
Organisation of medication
2.3
6.4
47
210
H50.1
ICD-10 Finland
Divergent concomitant strabismus
4.1
6.4
17
42
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
4.1
6.4
17
42
G44.2
ICD-10 Finland
Tension-type headache
1.5
6.4
224
1587
J01CA04
ATC
amoxicillin; systemic
1.4
6.3
1447
13504
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.8
6.3
89
503
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
6.3
188
1287
30180
ICD-8 Finland
Personality disorders, Immatura
9.3
6.3
12
13
R4120, ,
SPAT
3.4
6.3
22
66
SPAT1234
SPAT
Support of social functional capacity
2.0
6.3
64
325
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.8
6.3
95
549
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
18.1
6.3
9
5
F44.4
ICD-10 Finland
Dissociative motor disorders
18.1
6.3
9
5
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
2.2
6.3
48
218
34533
ICD-8 Finland
Epilepsy, Partialis (focalis) alia
+∞
6.3
6
*
31599
ICD-8 Finland
Unspecified mental retardation, Other and unspecified
+∞
6.3
6
*
34300
ICD-8 Finland
Cerebral spastic infantile paralysis, Hemiplegia spastica
+∞
6.3
6
*
199
Kela drug reimbursment
Rufinamide
+∞
6.3
6
*
3046, ,
Kela drug reimbursment
+∞
6.3
6
*
N03AX24
ATC
cannabidiol; oral
+∞
6.3
6
*
3457B
ICD-9 Finland
Epilepsy, Epilepsia partialis continua[EPILEPSIA PARTIALIS CONTINUA]
+∞
6.3
6
*
F73.0
ICD-10 Finland
Profound mental retardation, with the statement of no, or minimal, impairment of behaviour
+∞
6.3
6
*
AAJ15
NOMESCO Finland
Hippocampectomy
+∞
6.3
6
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
6.2
684
5792
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
3.0
6.2
26
87
2910A
ICD-9 Finland
Alcoholic psychoses, Alcohol withdrawal delirium
26.8
6.2
8
*
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
26.8
6.2
8
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
7.0
6.2
14
20
R13
ICD-10 Finland
Dysphagia
1.8
6.2
94
543
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
6.2
201
1400
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
6.2
158
1045
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.7
6.2
99
581
L16
ICPC
Ankle symptom/complaint
1.5
6.2
202
1409
L03
ICPC
Low back symptom/complaint
1.3
6.2
459
3684
F05
ICPC
Visual disturbance other
2.1
6.2
56
272
N05AA01
ATC
chlorpromazine; systemic, rectal
3.2
6.2
23
72
W10
ICD-10 Finland
Fall on and from stairs and steps
1.9
6.1
78
427
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.5
6.1
36
145
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
6.1
135
863
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.7
6.1
116
714
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
6.1
359
2782
Z71.8
ICD-10 Finland
Other specified counselling
1.3
6.1
578
4798
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.9
6.1
78
428
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.5
6.1
189
1305
A01
ICPC
Pain general/multiple sites
1.6
6.1
144
937
A03FA02
ATC
cisapride; oral, rectal
1.8
6.1
82
458
29599
ICD-8 Finland
Schizophrenia, Unspecified type
8.6
6.1
12
14
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
3.6
6.0
19
53
F50.9
ICD-10 Finland
Eating disorder, unspecified
2.7
6.0
30
111
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
6.0
887
7783
D01
ICPC
Abdominal pain/cramps general
1.5
6.0
225
1612
L84
ICPC
Back syndrome without radiat pain
1.9
6.0
78
430
AA3AD
NOMESCO Finland
CT of face
5.2
6.0
17
33
WYA20
NOMESCO Finland
Home visit
2.9
6.0
26
89

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
4.5e+00
5.2e+00
5.3e+00
—
6.2e+00
6.0e+00
5.6e+00
cases:20.40%
controls:0.27%
cases:24.17%
controls:0.18%
cases:8.01%
controls:0.04%
—
—
cases:16.98%
controls:0.04%
cases:38.96%
controls:0.16%
cases:43.81%
controls:0.30%
299
39
1167
14341
356
26
1117
14418
118
6
1355
14438
—
250
6
1222
14436
570
23
893
14374
619
42
794
13874
lamotrigine; oral
N03AX09 [21604431]
3.4e+00
4.1e+00
3.9e+00
—
4.7e+00
4.6e+00
4.7e+00
cases:5.05%
controls:0.17%
cases:4.96%
controls:0.08%
cases:2.04%
controls:0.04%
—
—
cases:4.21%
controls:0.04%
cases:10.73%
controls:0.13%
cases:15.57%
controls:0.17%
74
25
1392
14355
73
12
1400
14432
30
6
1443
14438
—
62
6
1410
14436
157
18
1306
14379
220
24
1193
13892
Neurology
13 [38004458]
2.4e+00
3.5e+00
3.9e+00
1.0e+50
4.2e+00
4.2e+00
3.5e+00
cases:25.38%
controls:2.98%
cases:29.94%
controls:1.31%
cases:9.37%
controls:0.21%
cases:61.98%
controls:0.00%
cases:12.84%
controls:0.23%
cases:47.92%
controls:1.36%
cases:60.37%
controls:4.35%
372
428
1094
13952
441
189
1032
14255
138
31
1335
14413
913
0
560
14444
189
33
1283
14409
701
196
762
14201
853
605
560
13311
Other and unspecified convulsions
R56.8 [45602033]
3.7e+00
5.0e+00
5.2e+00
1.0e+50
—
3.6e+00
2.7e+00
cases:9.75%
controls:0.26%
cases:13.99%
controls:0.11%
cases:6.04%
controls:0.03%
cases:2.31%
controls:0.00%
—
—
cases:3.76%
controls:0.10%
cases:4.60%
controls:0.33%
143
37
1323
14343
206
16
1267
14428
89
5
1384
14439
34
0
1439
14444
—
55
15
1408
14382
65
46
1348
13870
carbamazepine; oral, rectal
N03AF01 [21604417]
4.4e+00
4.8e+00
—
1.0e+50
—
5.6e+00
4.7e+00
cases:12.21%
controls:0.17%
cases:12.15%
controls:0.11%
—
—
cases:0.81%
controls:0.00%
—
—
cases:13.26%
controls:0.06%
cases:17.13%
controls:0.18%
179
25
1287
14355
179
16
1294
14428
—
12
0
1461
14444
—
194
8
1269
14389
242
25
1171
13891
clonazepam; oral, parenteral
N03AE01 [21604415]
2.9e+00
3.0e+00
2.5e+00
—
3.2e+00
3.1e+00
2.9e+00
cases:4.37%
controls:0.24%
cases:3.19%
controls:0.17%
cases:0.68%
controls:0.06%
—
—
cases:1.56%
controls:0.06%
cases:3.83%
controls:0.17%
cases:7.08%
controls:0.41%
64
35
1402
14345
47
24
1426
14420
10
8
1463
14436
—
23
9
1449
14433
56
25
1407
14372
100
57
1313
13859
Valproate [Moles/volume] in Serum or Plasma
14946-8 [3009466]
3.3e+00
3.6e+00
—
—
—
4.5e+00
4.8e+00
cases:1.16%
controls:0.04%
cases:1.56%
controls:0.04%
—
—
—
—
—
—
cases:4.31%
controls:0.05%
cases:5.80%
controls:0.05%
17
6
1449
14374
23
6
1450
14438
—
—
—
63
7
1400
14390
82
7
1331
13909
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
2.3e+00
2.8e+00
2.7e+00
1.0e+50
3.2e+00
2.3e+00
2.4e+00
cases:9.75%
controls:1.05%
cases:7.94%
controls:0.51%
cases:2.31%
controls:0.15%
cases:0.75%
controls:0.00%
cases:2.85%
controls:0.12%
cases:6.08%
controls:0.67%
cases:14.65%
controls:1.52%
143
151
1323
14229
117
74
1356
14370
34
22
1439
14422
11
0
1462
14444
42
18
1430
14424
89
96
1374
14301
207
211
1206
13705
clozapine; oral, parenteral
N05AH02 [21604542]
2.4e+00
2.5e+00
2.7e+00
—
2.8e+00
2.5e+00
2.3e+00
cases:1.09%
controls:0.10%
cases:1.29%
controls:0.10%
cases:0.88%
controls:0.06%
—
—
cases:1.09%
controls:0.07%
cases:1.44%
controls:0.12%
cases:1.56%
controls:0.15%
16
15
1450
14365
19
15
1454
14429
13
9
1460
14435
—
16
10
1456
14432
21
17
1442
14380
22
21
1391
13895
Paediatric neurology
421 [44777781]
1.4e+00
1.8e+00
2.6e+00
—
3.7e+00
2.8e+00
2.7e+00
cases:6.28%
controls:1.60%
cases:6.25%
controls:1.07%
cases:2.38%
controls:0.18%
—
—
cases:6.18%
controls:0.17%
cases:11.83%
controls:0.81%
cases:13.38%
controls:1.06%
92
230
1374
14150
92
154
1381
14290
35
26
1438
14418
—
91
24
1381
14418
173
116
1290
14281
189
148
1224
13768
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
1.0e+00
2.6e+00
3.2e+00
1.0e+50
3.1e+00
1.7e+00
1.2e+00
cases:1.98%
controls:0.70%
cases:4.07%
controls:0.33%
cases:0.81%
controls:0.03%
cases:0.75%
controls:0.00%
cases:0.75%
controls:0.03%
cases:1.78%
controls:0.34%
cases:4.74%
controls:1.44%
29
101
1437
14279
60
47
1413
14397
12
5
1461
14439
11
0
1462
14444
11
5
1461
14437
26
49
1437
14348
67
200
1346
13716
Psychiatry
26 [38004469]
1.3e+00
1.6e+00
1.7e+00
3.1e+00
1.7e+00
1.6e+00
1.4e+00
cases:9.69%
controls:2.79%
cases:7.33%
controls:1.52%
cases:2.99%
controls:0.57%
cases:1.90%
controls:0.08%
cases:3.13%
controls:0.59%
cases:8.00%
controls:1.65%
cases:16.42%
controls:4.53%
142
401
1324
13979
108
220
1365
14224
44
83
1429
14361
28
12
1445
14432
46
85
1426
14357
117
238
1346
14159
232
630
1181
13286
Outpatient Visit
OP [9202]
5.0e-01
8.3e-01
9.3e-01
5.9e+00
1.3e+00
1.4e+00
1.3e+00
cases:54.91%
controls:42.47%
cases:47.66%
controls:28.45%
cases:15.89%
controls:6.92%
cases:53.77%
controls:0.33%
cases:22.49%
controls:7.26%
cases:63.23%
controls:29.48%
cases:80.96%
controls:54.90%
805
6107
661
8273
702
4109
771
10335
234
999
1239
13445
792
47
681
14397
331
1048
1141
13394
925
4244
538
10153
1144
7640
269
6276
midazolam; nasal, oral, parenteral, sublingual
N05CD08 [21604643]
2.1e+00
3.1e+00
—
—
—
3.5e+00
3.4e+00
cases:0.75%
controls:0.09%
cases:0.95%
controls:0.04%
—
—
—
—
—
—
cases:1.30%
controls:0.04%
cases:3.11%
controls:0.11%
11
13
1455
14367
14
6
1459
14438
—
—
—
19
6
1444
14391
44
15
1369
13901
olanzapine; oral, parenteral
N05AH03 [21604543]
1.5e+00
1.8e+00
2.5e+00
—
2.5e+00
1.8e+00
1.8e+00
cases:1.09%
controls:0.26%
cases:1.22%
controls:0.21%
cases:0.61%
controls:0.05%
—
—
cases:0.75%
controls:0.06%
cases:1.44%
controls:0.23%
cases:2.83%
controls:0.50%
16
37
1450
14343
18
30
1455
14414
9
7
1464
14437
—
11
9
1461
14433
21
33
1442
14364
40
70
1373
13846
Unspecified nonorganic psychosis
F29 [45533099]
1.7e+00
2.3e+00
2.0e+00
—
1.8e+00
2.1e+00
1.9e+00
cases:1.23%
controls:0.22%
cases:0.88%
controls:0.09%
cases:0.48%
controls:0.06%
—
—
cases:0.48%
controls:0.08%
cases:0.82%
controls:0.10%
cases:1.77%
controls:0.28%
18
32
1448
14348
13
13
1460
14431
7
9
1466
14435
—
7
11
1465
14431
12
15
1451
14382
25
39
1388
13877
oxcarbazepine; oral
N03AF02 [21604418]
5.3e+00
—
—
1.0e+50
1.0e+50
—
6.3e+00
cases:9.28%
controls:0.05%
—
—
—
—
cases:1.22%
controls:0.00%
cases:7.00%
controls:0.00%
—
—
cases:16.28%
controls:0.04%
136
7
1330
14373
—
—
18
0
1455
14444
103
0
1369
14442
—
230
5
1183
13911
topiramate; oral
N03AX11 [21604433]
2.3e+00
2.5e+00
—
—
—
3.1e+00
3.1e+00
cases:1.64%
controls:0.17%
cases:1.29%
controls:0.10%
—
—
—
—
—
—
cases:2.60%
controls:0.12%
cases:5.31%
controls:0.26%
24
24
1442
14356
19
15
1454
14429
—
—
—
38
17
1425
14380
75
36
1338
13880
Internal Medicine
11 [38004456]
7.3e-01
1.1e+00
1.4e+00
5.1e+00
1.2e+00
6.9e-01
6.6e-01
cases:21.56%
controls:11.67%
cases:15.27%
controls:5.68%
cases:3.80%
controls:1.01%
cases:6.59%
controls:0.04%
cases:3.46%
controls:1.05%
cases:12.44%
controls:6.67%
cases:27.95%
controls:16.67%
316
1678
1150
12702
225
820
1248
13624
56
146
1417
14298
97
6
1376
14438
51
152
1421
14290
182
960
1281
13437
395
2320
1018
11596
risperidone; oral, parenteral
N05AX08 [21604559]
1.6e+00
1.9e+00
1.7e+00
—
2.3e+00
1.3e+00
1.7e+00
cases:1.91%
controls:0.38%
cases:1.43%
controls:0.22%
cases:0.54%
controls:0.10%
—
—
cases:0.48%
controls:0.05%
cases:1.09%
controls:0.29%
cases:3.40%
controls:0.62%
28
55
1438
14325
21
32
1452
14412
8
15
1465
14429
—
7
7
1465
14435
16
42
1447
14355
48
86
1365
13830
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
1.2e+00
2.3e+00
—
1.0e+50
—
3.3e+00
2.9e+00
cases:1.50%
controls:0.45%
cases:1.36%
controls:0.14%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.71%
controls:0.06%
cases:2.62%
controls:0.14%
22
65
1444
14315
20
20
1453
14424
—
5
0
1468
14444
—
25
9
1438
14388
37
20
1376
13896
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
2.1e-01
1.3e+00
1.8e+00
2.8e+00
1.5e+00
1.2e+00
8.3e-01
cases:2.86%
controls:2.34%
cases:4.96%
controls:1.42%
cases:1.63%
controls:0.26%
cases:0.68%
controls:0.04%
cases:1.09%
controls:0.26%
cases:3.62%
controls:1.09%
cases:6.30%
controls:2.85%
42
337
1424
14043
73
205
1400
14239
24
38
1449
14406
10
6
1463
14438
16
37
1456
14405
53
157
1410
14240
89
396
1324
13520
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
2.8e-01
1.2e+00
1.7e+00
3.0e+00
1.5e+00
1.2e+00
8.0e-01
cases:3.14%
controls:2.39%
cases:5.09%
controls:1.54%
cases:1.49%
controls:0.27%
cases:0.81%
controls:0.04%
cases:1.15%
controls:0.26%
cases:3.69%
controls:1.18%
cases:6.65%
controls:3.10%
46
344
1420
14036
75
222
1398
14222
22
39
1451
14405
12
6
1461
14438
17
37
1455
14405
54
170
1409
14227
94
431
1319
13485
Neuropsychological investigation
XA800 [2001300412]
1.6e+00
2.6e+00
—
—
—
2.4e+00
2.8e+00
cases:1.30%
controls:0.26%
cases:1.15%
controls:0.08%
—
—
—
—
—
—
cases:0.96%
controls:0.09%
cases:2.76%
controls:0.18%
19
37
1447
14343
17
12
1456
14432
—
—
—
14
13
1449
14384
39
25
1374
13891
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
2.2e+00
2.9e+00
—
1.0e+50
—
2.7e+00
1.5e+00
cases:1.23%
controls:0.14%
cases:0.95%
controls:0.06%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.09%
controls:0.08%
cases:1.20%
controls:0.27%
18
20
1448
14360
14
8
1459
14436
—
5
0
1468
14444
—
16
11
1447
14386
17
37
1396
13879
temazepam; oral
N05CD07 [21604642]
1.2e+00
1.5e+00
1.5e+00
—
1.9e+00
1.5e+00
1.3e+00
cases:3.07%
controls:0.95%
cases:2.31%
controls:0.55%
cases:0.75%
controls:0.17%
—
—
cases:0.82%
controls:0.12%
cases:2.60%
controls:0.58%
cases:5.10%
controls:1.43%
45
137
1421
14243
34
79
1439
14365
11
25
1462
14419
—
12
18
1460
14424
38
83
1425
14314
72
199
1341
13717
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
6.7e-01
6.8e-01
1.1e+00
2.9e+00
1.3e+00
1.1e+00
9.4e-01
cases:3.75%
controls:1.95%
cases:2.17%
controls:1.11%
cases:1.43%
controls:0.48%
cases:0.88%
controls:0.05%
cases:1.56%
controls:0.42%
cases:3.14%
controls:1.04%
cases:5.31%
controls:2.13%
55
281
1411
14099
32
160
1441
14284
21
69
1452
14375
13
7
1460
14437
23
60
1449
14382
46
150
1417
14247
75
297
1338
13619
Other specified special examinations
Z01.8 [45581003]
9.6e-01
1.0e+00
2.9e+00
—
2.0e+00
9.7e-01
8.8e-01
cases:3.14%
controls:1.23%
cases:1.15%
controls:0.42%
cases:0.88%
controls:0.05%
—
—
cases:0.41%
controls:0.06%
cases:1.44%
controls:0.55%
cases:3.82%
controls:1.62%
46
177
1420
14203
17
61
1456
14383
13
7
1460
14437
—
6
8
1466
14434
21
79
1442
14318
54
226
1359
13690
oxazepam; oral
N05BA04 [21604569]
1.2e+00
1.5e+00
1.6e+00
—
1.9e+00
1.2e+00
1.1e+00
cases:4.50%
controls:1.45%
cases:3.33%
controls:0.74%
cases:0.95%
controls:0.19%
—
—
cases:1.15%
controls:0.18%
cases:3.01%
controls:0.93%
cases:7.01%
controls:2.47%
66
208
1400
14172
49
107
1424
14337
14
28
1459
14416
—
17
26
1455
14416
44
134
1419
14263
99
344
1314
13572
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.4e-01
8.1e-01
1.5e+00
3.3e+00
1.7e+00
7.1e-01
4.4e-01
cases:6.68%
controls:5.86%
cases:9.23%
controls:4.34%
cases:3.94%
controls:0.87%
cases:1.97%
controls:0.08%
cases:3.60%
controls:0.70%
cases:8.20%
controls:4.22%
cases:15.43%
controls:10.50%
98
843
1368
13537
136
627
1337
13817
58
126
1415
14318
29
11
1444
14433
53
101
1419
14341
120
608
1343
13789
218
1461
1195
12455
Pharmacy visit
OMOP4822462 [581458]
2.5e-01
7.3e-01
8.1e-01
2.6e+00
1.4e+00
1.3e+00
1.2e+00
cases:75.44%
controls:70.54%
cases:74.34%
controls:58.22%
cases:38.56%
controls:21.79%
cases:12.83%
controls:1.09%
cases:52.11%
controls:21.92%
cases:85.58%
controls:61.06%
cases:96.04%
controls:87.53%
1106
10143
360
4237
1095
8409
378
6035
568
3147
905
11297
189
158
1284
14286
767
3166
705
11276
1252
8791
211
5606
1357
12180
56
1736
Inpatient Visit
IP [9201]
5.7e-01
1.2e+00
2.0e+00
—
2.5e+00
1.3e+00
8.2e-01
cases:16.37%
controls:10.01%
cases:7.88%
controls:2.63%
cases:1.83%
controls:0.26%
—
—
cases:2.58%
controls:0.22%
cases:7.04%
controls:2.06%
cases:8.70%
controls:4.04%
240
1439
1226
12941
116
380
1357
14064
27
38
1446
14406
—
38
32
1434
14410
103
297
1360
14100
123
562
1290
13354
Severe psychotic and other severe mental disorders
112 [2001600112]
1.8e+00
1.9e+00
—
—
—
2.7e+00
1.8e+00
cases:2.18%
controls:0.38%
cases:0.88%
controls:0.13%
—
—
—
—
—
—
cases:0.62%
controls:0.04%
cases:2.05%
controls:0.33%
32
54
1434
14326
13
19
1460
14425
—
—
—
9
6
1454
14391
29
46
1384
13870
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
1.8e+00
2.6e+00
—
—
2.3e+00
2.2e+00
1.7e+00
cases:1.98%
controls:0.35%
cases:1.70%
controls:0.13%
—
—
—
—
cases:0.34%
controls:0.03%
cases:0.96%
controls:0.11%
cases:2.12%
controls:0.40%
29
50
1437
14330
25
19
1448
14425
—
—
5
5
1467
14437
14
16
1449
14381
30
56
1383
13860
Neurosurgery
14 [38004459]
1.7e+00
2.1e+00
1.9e+00
1.0e+50
1.8e+00
2.2e+00
1.9e+00
cases:3.89%
controls:0.74%
cases:2.17%
controls:0.26%
cases:0.41%
controls:0.06%
cases:0.48%
controls:0.00%
cases:0.34%
controls:0.06%
cases:2.32%
controls:0.26%
cases:4.74%
controls:0.71%
57
106
1409
14274
32
38
1441
14406
6
9
1467
14435
7
0
1466
14444
5
8
1467
14434
34
37
1429
14360
67
99
1346
13817
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.3e-01
7.6e-01
1.3e+00
3.3e+00
1.5e+00
5.5e-01
4.1e-01
cases:6.68%
controls:5.92%
cases:8.96%
controls:4.39%
cases:3.19%
controls:0.87%
cases:1.90%
controls:0.07%
cases:3.13%
controls:0.71%
cases:7.18%
controls:4.25%
cases:15.00%
controls:10.51%
98
851
1368
13529
132
634
1341
13810
47
126
1426
14318
28
10
1445
14434
46
102
1426
14340
105
612
1358
13785
212
1463
1201
12453
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
1.1e+00
2.5e+00
—
1.0e+50
—
2.2e+00
2.0e+00
cases:1.23%
controls:0.40%
cases:1.22%
controls:0.10%
—
—
cases:0.54%
controls:0.00%
—
—
cases:0.68%
controls:0.08%
cases:1.84%
controls:0.26%
18
57
1448
14323
18
14
1455
14430
—
8
0
1465
14444
—
10
11
1453
14386
26
36
1387
13880
Case Management Agency
251B00000X [38004193]
7.7e-01
6.2e-01
1.1e+00
2.8e+00
1.3e+00
6.2e-01
5.9e-01
cases:41.61%
controls:24.90%
cases:31.91%
controls:20.06%
cases:19.62%
controls:7.35%
cases:7.67%
controls:0.48%
cases:21.94%
controls:7.37%
cases:34.04%
controls:21.66%
cases:51.88%
controls:37.30%
610
3580
856
10800
470
2898
1003
11546
289
1062
1184
13382
113
70
1360
14374
323
1064
1149
13378
498
3118
965
11279
733
5190
680
8726
General Practice
1 [38004446]
5.4e-01
1.1e+00
1.7e+00
1.0e+50
2.1e+00
1.4e+00
9.1e-01
cases:7.91%
controls:4.78%
cases:5.57%
controls:1.84%
cases:1.36%
controls:0.25%
cases:2.78%
controls:0.00%
cases:1.83%
controls:0.22%
cases:6.49%
controls:1.69%
cases:15.64%
controls:6.93%
116
688
1350
13692
82
266
1391
14178
20
36
1453
14408
41
0
1432
14444
27
32
1445
14410
95
244
1368
14153
221
964
1192
12952
nitrazepam; oral
N05CD02 [21604637]
2.7e+00
2.9e+00
—
—
—
—
2.2e+00
cases:0.61%
controls:0.04%
cases:0.61%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.10%
9
6
1457
14374
9
5
1464
14439
—
—
—
—
13
14
1400
13902
CBC panel - Blood by Automated count
58410-2 [40761511]
8.4e-02
4.8e-01
1.4e+00
3.5e+00
1.4e+00
6.2e-01
3.0e-01
cases:7.50%
controls:6.94%
cases:7.40%
controls:4.71%
cases:3.19%
controls:0.82%
cases:1.77%
controls:0.06%
cases:2.99%
controls:0.77%
cases:8.00%
controls:4.48%
cases:15.00%
controls:11.57%
110
998
1356
13382
109
680
1364
13764
47
119
1426
14325
26
8
1447
14436
44
111
1428
14331
117
645
1346
13752
212
1610
1201
12306
Anxiety disorder, unspecified
F41.9 [45542849]
1.3e+00
1.5e+00
—
—
2.0e+00
1.7e+00
1.2e+00
cases:1.43%
controls:0.41%
cases:1.02%
controls:0.23%
—
—
—
—
cases:0.41%
controls:0.06%
cases:1.23%
controls:0.23%
cases:2.97%
controls:0.94%
21
59
1445
14321
15
33
1458
14411
—
—
6
8
1466
14434
18
33
1445
14364
42
131
1371
13785
levomepromazine; oral, parenteral
N05AA02 [21604493]
1.8e+00
2.1e+00
—
—
2.3e+00
1.7e+00
2.0e+00
cases:1.09%
controls:0.19%
cases:0.81%
controls:0.10%
—
—
—
—
cases:0.34%
controls:0.03%
cases:0.68%
controls:0.13%
cases:1.98%
controls:0.27%
16
27
1450
14353
12
14
1461
14430
—
—
5
5
1467
14437
10
18
1453
14379
28
38
1385
13878
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
-1.9e-02
4.7e-01
1.2e+00
3.2e+00
1.6e+00
7.0e-01
4.3e-01
cases:6.00%
controls:6.11%
cases:7.81%
controls:5.05%
cases:3.73%
controls:1.15%
cases:2.38%
controls:0.10%
cases:4.48%
controls:0.96%
cases:9.23%
controls:4.80%
cases:14.79%
controls:10.15%
88
879
1378
13501
115
729
1358
13715
55
166
1418
14278
35
14
1438
14430
66
138
1406
14304
135
691
1328
13706
209
1413
1204
12503
Medical doctor
Z2221 [2001311556]
7.0e-01
1.1e+00
1.6e+00
1.0e+50
1.5e+00
1.4e+00
1.3e+00
cases:4.30%
controls:2.19%
cases:2.51%
controls:0.89%
cases:0.75%
controls:0.15%
cases:0.34%
controls:0.00%
cases:0.61%
controls:0.13%
cases:2.73%
controls:0.72%
cases:7.57%
controls:2.18%
63
315
1403
14065
37
129
1436
14315
11
21
1462
14423
5
0
1468
14444
9
19
1463
14423
40
104
1423
14293
107
304
1306
13612
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
1.7e+00
3.3e+00
—
—
—
2.4e+00
1.8e+00
cases:0.34%
controls:0.06%
cases:0.95%
controls:0.03%
—
—
—
—
—
—
cases:0.48%
controls:0.04%
cases:0.92%
controls:0.16%
5
9
1461
14371
14
5
1459
14439
—
—
—
7
6
1456
14391
13
22
1400
13894
Emergency Room Visit
ER [9203]
6.4e-01
1.4e+00
2.2e+00
—
1.6e+00
9.7e-01
7.5e-01
cases:30.22%
controls:18.59%
cases:23.42%
controls:7.32%
cases:7.33%
controls:0.89%
—
—
cases:4.42%
controls:0.95%
cases:17.09%
controls:7.27%
cases:40.34%
controls:24.22%
443
2673
1023
11707
345
1057
1128
13387
108
129
1365
14315
—
65
137
1407
14305
250
1047
1213
13350
570
3371
843
10545
Inpatient Hospital
21 [8717]
4.5e-01
1.1e+00
2.1e+00
—
2.0e+00
1.0e+00
8.1e-01
cases:34.65%
controls:25.23%
cases:20.64%
controls:8.21%
cases:7.13%
controls:0.97%
—
—
cases:7.27%
controls:1.00%
cases:20.23%
controls:8.41%
cases:45.22%
controls:26.89%
508
3628
958
10752
304
1186
1169
13258
105
140
1368
14304
—
107
145
1365
14297
296
1211
1167
13186
639
3742
774
10174
Office Visit
OMOP4822458 [581477]
6.1e-01
9.6e-01
1.7e+00
—
2.2e+00
8.2e-01
9.0e-01
cases:11.19%
controls:6.38%
cases:6.25%
controls:2.50%
cases:1.63%
controls:0.30%
—
—
cases:2.65%
controls:0.30%
cases:6.08%
controls:2.76%
cases:15.78%
controls:7.08%
164
918
1302
13462
92
361
1381
14083
24
43
1449
14401
—
39
44
1433
14398
89
398
1374
13999
223
985
1190
12931
disulfiram; oral
N07BB01 [21604821]
1.4e+00
2.3e+00
—
—
—
1.9e+00
1.6e+00
cases:0.75%
controls:0.19%
cases:0.54%
controls:0.06%
—
—
—
—
—
—
cases:0.48%
controls:0.07%
cases:1.13%
controls:0.24%
11
27
1455
14353
8
8
1465
14436
—
—
—
7
10
1456
14387
16
33
1397
13883
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
1.9e+00
2.3e+00
—
—
—
1.8e+00
1.1e+00
cases:0.82%
controls:0.12%
cases:0.48%
controls:0.05%
—
—
—
—
—
—
cases:0.75%
controls:0.13%
cases:1.06%
controls:0.35%
12
17
1454
14363
7
7
1466
14437
—
—
—
11
18
1452
14379
15
49
1398
13867
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
1.6e+00
1.9e+00
—
—
—
2.2e+00
1.4e+00
cases:1.02%
controls:0.22%
cases:0.88%
controls:0.13%
—
—
—
—
—
—
cases:0.96%
controls:0.11%
cases:1.63%
controls:0.39%
15
31
1451
14349
13
19
1460
14425
—
—
—
14
16
1449
14381
23
54
1390
13862
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.3e-01
6.4e-01
1.4e+00
3.5e+00
1.2e+00
3.4e-01
3.2e-01
cases:7.23%
controls:6.40%
cases:7.88%
controls:4.30%
cases:2.99%
controls:0.79%
cases:1.83%
controls:0.06%
cases:2.31%
controls:0.70%
cases:6.22%
controls:4.50%
cases:14.72%
controls:11.12%
106
921
1360
13459
116
621
1357
13823
44
114
1429
14330
27
8
1446
14436
34
101
1438
14341
91
648
1372
13749
208
1547
1205
12369
quetiapine; oral
N05AH04 [21604544]
1.5e+00
1.3e+00
1.6e+00
—
1.5e+00
1.4e+00
1.3e+00
cases:3.75%
controls:0.89%
cases:2.10%
controls:0.60%
cases:0.88%
controls:0.19%
—
—
cases:0.54%
controls:0.12%
cases:2.67%
controls:0.64%
cases:6.16%
controls:1.76%
55
128
1411
14252
31
87
1442
14357
13
27
1460
14417
—
8
17
1464
14425
39
92
1424
14305
87
245
1326
13671
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
1.4e+00
2.0e+00
—
—
2.3e+00
1.7e+00
1.9e+00
cases:0.95%
controls:0.24%
cases:0.88%
controls:0.12%
—
—
—
—
cases:0.34%
controls:0.03%
cases:0.68%
controls:0.13%
cases:1.63%
controls:0.24%
14
35
1452
14345
13
18
1460
14426
—
—
5
5
1467
14437
10
18
1453
14379
23
34
1390
13882
Platelets [#/volume] in Blood
26515-7 [3007461]
7.3e-02
4.1e-01
1.1e+00
3.2e+00
1.3e+00
5.5e-01
2.8e-01
cases:9.07%
controls:8.49%
cases:10.12%
controls:6.94%
cases:4.48%
controls:1.50%
cases:2.99%
controls:0.12%
cases:5.16%
controls:1.42%
cases:11.76%
controls:7.14%
cases:19.18%
controls:15.20%
133
1221
1333
13159
149
1002
1324
13442
66
217
1407
14227
44
18
1429
14426
76
205
1396
14237
172
1028
1291
13369
271
2115
1142
11801
Pediatric Medicine
37 [38004477]
-7.7e-02
5.9e-02
7.1e-01
5.1e+00
7.0e-01
1.9e-01
3.6e-01
cases:12.69%
controls:13.57%
cases:7.81%
controls:7.39%
cases:3.73%
controls:1.87%
cases:6.52%
controls:0.04%
cases:3.80%
controls:1.92%
cases:7.72%
controls:6.49%
cases:10.83%
controls:7.81%
186
1951
1280
12429
115
1068
1358
13376
55
270
1418
14174
96
6
1377
14438
56
277
1416
14165
113
934
1350
13463
153
1087
1260
12829
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
7.2e-02
4.1e-01
1.1e+00
3.2e+00
1.3e+00
5.5e-01
2.7e-01
cases:9.07%
controls:8.50%
cases:10.12%
controls:6.97%
cases:4.48%
controls:1.50%
cases:2.99%
controls:0.12%
cases:5.16%
controls:1.42%
cases:11.76%
controls:7.15%
cases:19.18%
controls:15.28%
133
1222
1333
13158
149
1007
1324
13437
66
216
1407
14228
44
18
1429
14426
76
205
1396
14237
172
1029
1291
13368
271
2126
1142
11790
MCH [Entitic mass]
28539-5 [3035941]
7.4e-02
4.0e-01
1.1e+00
3.2e+00
1.3e+00
5.5e-01
2.7e-01
cases:9.07%
controls:8.48%
cases:10.12%
controls:6.99%
cases:4.48%
controls:1.50%
cases:2.99%
controls:0.12%
cases:5.16%
controls:1.42%
cases:11.76%
controls:7.15%
cases:19.11%
controls:15.26%
133
1219
1333
13161
149
1009
1324
13435
66
217
1407
14227
44
18
1429
14426
76
205
1396
14237
172
1030
1291
13367
270
2124
1143
11792
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
7.3e-02
4.0e-01
1.1e+00
3.2e+00
1.3e+00
5.5e-01
2.7e-01
cases:9.07%
controls:8.49%
cases:10.12%
controls:7.00%
cases:4.48%
controls:1.50%
cases:2.99%
controls:0.12%
cases:5.16%
controls:1.42%
cases:11.76%
controls:7.16%
cases:19.18%
controls:15.28%
133
1221
1333
13159
149
1011
1324
13433
66
217
1407
14227
44
18
1429
14426
76
205
1396
14237
172
1031
1291
13366
271
2127
1142
11789
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
7.2e-02
4.0e-01
1.1e+00
3.2e+00
1.3e+00
5.5e-01
2.7e-01
cases:9.07%
controls:8.50%
cases:10.12%
controls:7.00%
cases:4.48%
controls:1.50%
cases:2.99%
controls:0.12%
cases:5.16%
controls:1.42%
cases:11.76%
controls:7.16%
cases:19.18%
controls:15.30%
133
1222
1333
13158
149
1011
1324
13433
66
217
1407
14227
44
18
1429
14426
76
205
1396
14237
172
1031
1291
13366
271
2129
1142
11787
Leukocytes [#/volume] in Blood
26464-8 [3010813]
7.0e-02
4.0e-01
1.1e+00
3.2e+00
1.3e+00
5.5e-01
2.8e-01
cases:9.07%
controls:8.51%
cases:10.12%
controls:6.99%
cases:4.48%
controls:1.51%
cases:2.99%
controls:0.12%
cases:5.16%
controls:1.43%
cases:11.76%
controls:7.17%
cases:19.25%
controls:15.31%
133
1224
1333
13156
149
1010
1324
13434
66
218
1407
14226
44
18
1429
14426
76
206
1396
14236
172
1032
1291
13365
272
2130
1141
11786
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
7.2e-02
4.0e-01
1.1e+00
3.2e+00
1.3e+00
5.4e-01
2.7e-01
cases:9.07%
controls:8.50%
cases:10.12%
controls:7.01%
cases:4.48%
controls:1.50%
cases:2.99%
controls:0.12%
cases:5.16%
controls:1.43%
cases:11.76%
controls:7.18%
cases:19.18%
controls:15.32%
133
1222
1333
13158
149
1013
1324
13431
66
217
1407
14227
44
18
1429
14426
76
206
1396
14236
172
1033
1291
13364
271
2132
1142
11784
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
7.4e-02
5.7e-01
1.1e+00
3.6e+00
1.2e+00
3.8e-01
2.4e-01
cases:6.89%
controls:6.43%
cases:8.49%
controls:4.99%
cases:3.12%
controls:1.05%
cases:1.97%
controls:0.06%
cases:2.72%
controls:0.85%
cases:7.18%
controls:5.03%
cases:14.93%
controls:12.09%
101
925
1365
13455
125
721
1348
13723
46
152
1427
14292
29
8
1444
14436
40
123
1432
14319
105
724
1358
13673
211
1682
1202
12234
Observation for suspected nervous system disorder
Z03.3 [45609903]
8.6e-01
2.5e+00
—
—
—
2.5e+00
1.8e+00
cases:0.75%
controls:0.32%
cases:1.22%
controls:0.10%
—
—
—
—
—
—
cases:0.82%
controls:0.07%
cases:1.84%
controls:0.32%
11
46
1455
14334
18
14
1455
14430
—
—
—
12
10
1451
14387
26
44
1387
13872
Psychologist
Z2445 [2001311558]
9.2e-01
1.6e+00
—
—
2.1e+00
1.7e+00
2.5e+00
cases:1.36%
controls:0.55%
cases:0.95%
controls:0.19%
—
—
—
—
cases:0.34%
controls:0.04%
cases:1.03%
controls:0.18%
cases:2.62%
controls:0.23%
20
79
1446
14301
14
27
1459
14417
—
—
5
6
1467
14436
15
26
1448
14371
37
32
1376
13884
Paranoid schizophrenia continuous
F20.00 [2000501920]
2.0e+00
2.2e+00
-1.0e+50
—
—
1.5e+00
2.4e+00
cases:0.48%
controls:0.06%
cases:0.54%
controls:0.06%
cases:0.00%
controls:0.04%
—
—
—
—
cases:0.34%
controls:0.08%
cases:0.85%
controls:0.08%
7
9
1459
14371
8
9
1465
14435
0
6
1473
14438
—
—
5
11
1458
14386
12
11
1401
13905
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
1.3e+00
2.0e+00
—
—
—
1.8e+00
1.6e+00
cases:1.09%
controls:0.31%
cases:0.68%
controls:0.10%
—
—
—
—
—
—
cases:0.62%
controls:0.10%
cases:2.12%
controls:0.45%
16
44
1450
14336
10
14
1463
14430
—
—
—
9
15
1454
14382
30
63
1383
13853
Cerebral infarction, unspecified
I63.9 [45596216]
1.6e+00
2.4e+00
—
1.0e+50
—
2.6e+00
6.4e-01
cases:0.89%
controls:0.18%
cases:0.75%
controls:0.07%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.55%
controls:0.04%
cases:0.64%
controls:0.34%
13
26
1453
14354
11
10
1462
14434
—
5
0
1468
14444
—
8
6
1455
14391
9
47
1404
13869
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
4.9e-02
3.8e-01
1.1e+00
3.1e+00
1.4e+00
5.5e-01
1.9e-01
cases:7.30%
controls:6.97%
cases:7.81%
controls:5.45%
cases:3.46%
controls:1.18%
cases:2.44%
controls:0.11%
cases:4.21%
controls:1.11%
cases:9.02%
controls:5.41%
cases:14.15%
controls:12.01%
107
1003
1359
13377
115
787
1358
13657
51
170
1422
14274
36
16
1437
14428
62
160
1410
14282
132
779
1331
13618
200
1671
1213
12245
Syncope and collapse
R55 [45568141]
1.8e+00
3.0e+00
—
1.0e+50
—
1.5e+00
8.8e-01
cases:1.91%
controls:0.32%
cases:1.97%
controls:0.10%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.62%
controls:0.13%
cases:1.13%
controls:0.47%
28
46
1438
14334
29
15
1444
14429
—
5
0
1468
14444
—
9
19
1454
14378
16
66
1397
13850
zolpidem; oral
N05CF02 [21604655]
9.8e-01
1.3e+00
1.5e+00
—
2.1e+00
1.1e+00
6.9e-01
cases:1.91%
controls:0.72%
cases:1.43%
controls:0.39%
cases:0.34%
controls:0.08%
—
—
cases:0.54%
controls:0.07%
cases:1.50%
controls:0.51%
cases:2.90%
controls:1.47%
28
104
1438
14276
21
56
1452
14388
5
11
1468
14433
—
8
10
1464
14432
22
73
1441
14324
41
205
1372
13711
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
4.8e-01
1.1e+00
1.6e+00
—
1.3e+00
1.0e+00
6.6e-01
cases:4.02%
controls:2.53%
cases:4.68%
controls:1.59%
cases:1.36%
controls:0.29%
—
—
cases:0.88%
controls:0.25%
cases:3.49%
controls:1.26%
cases:7.43%
controls:3.98%
59
364
1407
14016
69
229
1404
14215
20
42
1453
14402
—
13
36
1459
14406
51
182
1412
14215
105
554
1308
13362
Respiratory and circulatory monitoring
WX700 [2001310817]
1.1e+00
1.9e+00
—
—
—
1.6e+00
1.5e+00
cases:1.84%
controls:0.60%
cases:1.22%
controls:0.19%
—
—
—
—
—
—
cases:0.82%
controls:0.17%
cases:2.83%
controls:0.64%
27
86
1439
14294
18
27
1455
14417
—
—
—
12
25
1451
14372
40
89
1373
13827
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
O99.3 [45606675]
2.5e+00
—
—
—
—
—
3.6e+00
cases:0.41%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
cases:3.11%
controls:0.09%
6
5
1460
14375
—
—
—
—
—
44
12
1369
13904
doxepin; oral, parenteral
N06AA12 [21604699]
1.5e+00
1.4e+00
—
—
—
1.5e+00
1.4e+00
cases:1.23%
controls:0.26%
cases:0.75%
controls:0.18%
—
—
—
—
—
—
cases:0.68%
controls:0.16%
cases:1.42%
controls:0.34%
18
38
1448
14342
11
26
1462
14418
—
—
—
10
23
1453
14374
20
48
1393
13868
mirtazapine; oral
N06AX11 [21604740]
1.0e+00
1.5e+00
1.1e+00
—
1.4e+00
1.2e+00
7.4e-01
cases:3.62%
controls:1.36%
cases:2.99%
controls:0.71%
cases:0.61%
controls:0.20%
—
—
cases:0.75%
controls:0.19%
cases:2.73%
controls:0.81%
cases:5.31%
controls:2.61%
53
196
1413
14184
44
102
1429
14342
9
29
1464
14415
—
11
27
1461
14415
40
116
1423
14281
75
363
1338
13553
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
1.8e+00
2.2e+00
—
—
—
1.5e+00
1.8e+00
cases:0.95%
controls:0.16%
cases:0.54%
controls:0.06%
—
—
—
—
—
—
cases:0.34%
controls:0.08%
cases:1.84%
controls:0.31%
14
23
1452
14357
8
9
1465
14435
—
—
—
5
11
1458
14386
26
43
1387
13873
pH of Serum or Plasma
2753-2 [3018418]
4.4e-01
1.6e+00
2.1e+00
—
1.8e+00
1.3e+00
7.0e-01
cases:1.50%
controls:0.97%
cases:2.38%
controls:0.47%
cases:0.41%
controls:0.05%
—
—
cases:0.41%
controls:0.07%
cases:1.78%
controls:0.51%
cases:3.40%
controls:1.72%
22
140
1444
14240
35
68
1438
14376
6
7
1467
14437
—
6
10
1466
14432
26
74
1437
14323
48
240
1365
13676
Poisoning by systemic antibiotics
T36 [45756588]
1.6e+00
2.3e+00
—
—
—
1.5e+00
1.7e+00
cases:1.09%
controls:0.22%
cases:0.75%
controls:0.08%
—
—
—
—
—
—
cases:0.41%
controls:0.09%
cases:2.05%
controls:0.37%
16
32
1450
14348
11
11
1462
14433
—
—
—
6
13
1457
14384
29
51
1384
13865
chlordiazepoxide; oral, parenteral
N05BA02 [21604567]
1.7e+00
—
—
—
—
2.3e+00
1.6e+00
cases:0.61%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.55%
controls:0.06%
cases:0.85%
controls:0.17%
9
17
1457
14363
—
—
—
—
8
8
1455
14389
12
23
1401
13893
Outpatient Hospital
22 [8756]
3.5e-01
8.9e-01
1.5e+00
—
1.3e+00
8.0e-01
7.0e-01
cases:20.74%
controls:15.55%
cases:10.79%
controls:4.74%
cases:2.51%
controls:0.57%
—
—
cases:1.90%
controls:0.53%
cases:10.46%
controls:4.99%
cases:30.22%
controls:17.67%
304
2236
1162
12144
159
684
1314
13760
37
83
1436
14361
—
28
77
1444
14365
153
719
1310
13678
427
2459
986
11457
chlorprothixene; oral, parenteral
N05AF03 [21604533]
1.7e+00
1.1e+00
—
—
—
2.0e+00
1.8e+00
cases:1.02%
controls:0.18%
cases:0.41%
controls:0.14%
—
—
—
—
—
—
cases:0.55%
controls:0.08%
cases:0.85%
controls:0.14%
15
26
1451
14354
6
20
1467
14424
—
—
—
8
11
1455
14386
12
20
1401
13896
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
3.0e+00
—
—
—
—
—
2.4e+00
cases:0.95%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.11%
14
7
1452
14373
—
—
—
—
—
17
16
1396
13900
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
—
2.3e+00
—
—
—
—
3.0e+00
—
—
cases:0.48%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.05%
—
7
7
1466
14437
—
—
—
—
14
7
1399
13909
Supplier / Service Provider
OMOP5117446 [33004]
-1.5e+00
-1.7e+00
—
—
2.4e+00
2.9e+00
3.1e+00
cases:6.89%
controls:24.79%
cases:2.10%
controls:10.19%
—
—
—
—
cases:0.54%
controls:0.05%
cases:3.01%
controls:0.17%
cases:9.34%
controls:0.48%
101
3565
1365
10815
31
1472
1442
12972
—
—
8
7
1464
14435
44
24
1419
14373
132
67
1281
13849
Emergency Medicine
93 [38004510]
8.6e-02
9.3e-01
1.8e+00
1.0e+50
1.4e+00
6.7e-01
4.8e-01
cases:3.07%
controls:2.82%
cases:4.89%
controls:1.98%
cases:1.49%
controls:0.26%
cases:1.43%
controls:0.00%
cases:0.88%
controls:0.23%
cases:3.76%
controls:1.96%
cases:9.84%
controls:6.31%
45
406
1421
13974
72
286
1401
14158
22
37
1451
14407
21
0
1452
14444
13
33
1459
14409
55
282
1408
14115
139
878
1274
13038
Social worker
Z2446 [2001311559]
8.5e-01
1.1e+00
—
1.0e+50
—
2.2e+00
2.0e+00
cases:1.71%
controls:0.74%
cases:0.68%
controls:0.22%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.16%
controls:0.13%
cases:2.55%
controls:0.34%
25
106
1441
14274
10
32
1463
14412
—
5
0
1468
14444
—
17
19
1446
14378
36
47
1377
13869
Laboratory Visit
OMOP4822461 [32036]
6.9e-03
2.1e-01
9.8e-01
2.7e+00
1.1e+00
2.8e-01
1.3e-01
cases:10.30%
controls:10.24%
cases:11.81%
controls:9.81%
cases:7.26%
controls:2.86%
cases:3.33%
controls:0.23%
cases:7.27%
controls:2.60%
cases:13.47%
controls:10.56%
cases:20.88%
controls:18.87%
151
1472
1315
12908
174
1417
1299
13027
107
413
1366
14031
49
33
1424
14411
107
376
1365
14066
197
1521
1266
12876
295
2626
1118
11290
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.3e+00
1.4e+00
—
—
—
2.1e+00
1.5e+00
cases:1.16%
controls:0.31%
cases:0.54%
controls:0.14%
—
—
—
—
—
—
cases:1.37%
controls:0.17%
cases:1.70%
controls:0.40%
17
44
1449
14336
8
20
1465
14424
—
—
—
20
25
1443
14372
24
55
1389
13861
aripiprazole; oral, parenteral
N05AX12 [21604562]
1.9e+00
1.5e+00
—
—
—
1.2e+00
1.5e+00
cases:0.82%
controls:0.13%
cases:0.61%
controls:0.14%
—
—
—
—
—
—
cases:0.55%
controls:0.17%
cases:1.27%
controls:0.29%
12
18
1454
14362
9
20
1464
14424
—
—
—
8
24
1455
14373
18
40
1395
13876
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
-3.4e-02
2.8e-01
2.5e-01
2.4e+00
1.1e+00
8.2e-01
5.1e-01
cases:3.41%
controls:3.53%
cases:2.92%
controls:2.23%
cases:0.61%
controls:0.48%
cases:0.54%
controls:0.05%
cases:1.43%
controls:0.49%
cases:4.58%
controls:2.07%
cases:7.64%
controls:4.74%
50
507
1416
13873
43
322
1430
14122
9
69
1464
14375
8
7
1465
14437
21
71
1451
14371
67
298
1396
14099
108
660
1305
13256
Obstetrics / Gynecology
16 [38004461]
1.1e-01
8.2e-02
7.5e-01
3.7e+00
4.2e-01
1.7e-01
3.8e-01
cases:13.30%
controls:12.04%
cases:5.50%
controls:5.09%
cases:1.77%
controls:0.84%
cases:2.17%
controls:0.06%
cases:1.36%
controls:0.89%
cases:6.56%
controls:5.58%
cases:21.09%
controls:15.47%
195
1731
1271
12649
81
735
1392
13709
26
122
1447
14322
32
8
1441
14436
20
129
1452
14313
96
803
1367
13594
298
2153
1115
11763
Monocytes/Leukocytes in Blood
26485-3 [3019069]
-5.5e-02
2.6e-01
2.4e-01
2.3e+00
1.2e+00
7.9e-01
5.7e-01
cases:2.93%
controls:3.09%
cases:2.51%
controls:1.95%
cases:0.54%
controls:0.43%
cases:0.41%
controls:0.04%
cases:1.22%
controls:0.38%
cases:3.96%
controls:1.85%
cases:6.86%
controls:4.01%
43
445
1423
13935
37
282
1436
14162
8
62
1465
14382
6
6
1467
14438
18
55
1454
14387
58
266
1405
14131
97
558
1316
13358
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
1.0e+00
1.5e+00
—
—
—
1.3e+00
1.0e+00
cases:1.09%
controls:0.40%
cases:0.75%
controls:0.17%
—
—
—
—
—
—
cases:0.82%
controls:0.22%
cases:2.97%
controls:1.09%
16
58
1450
14322
11
25
1462
14419
—
—
—
12
32
1451
14365
42
151
1371
13765
Basophils/Leukocytes in Blood
30180-4 [3022096]
-4.8e-02
2.6e-01
1.0e-01
2.3e+00
1.2e+00
7.7e-01
5.6e-01
cases:2.93%
controls:3.07%
cases:2.51%
controls:1.95%
cases:0.48%
controls:0.43%
cases:0.41%
controls:0.04%
cases:1.22%
controls:0.38%
cases:3.90%
controls:1.84%
cases:6.86%
controls:4.02%
43
442
1423
13938
37
281
1436
14163
7
62
1466
14382
6
6
1467
14438
18
55
1454
14387
57
265
1406
14132
97
560
1316
13356
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
-5.1e-02
2.6e-01
2.4e-01
2.3e+00
1.2e+00
7.6e-01
5.6e-01
cases:2.93%
controls:3.08%
cases:2.51%
controls:1.95%
cases:0.54%
controls:0.43%
cases:0.41%
controls:0.04%
cases:1.22%
controls:0.38%
cases:3.90%
controls:1.85%
cases:6.86%
controls:4.03%
43
443
1423
13937
37
282
1436
14162
8
62
1465
14382
6
6
1467
14438
18
55
1454
14387
57
267
1406
14130
97
561
1316
13355
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
-5.4e-02
3.1e-01
-3.6e-02
2.3e+00
1.2e+00
7.5e-01
5.4e-01
cases:3.00%
controls:3.16%
cases:2.65%
controls:1.96%
cases:0.41%
controls:0.42%
cases:0.41%
controls:0.04%
cases:1.22%
controls:0.38%
cases:3.83%
controls:1.84%
cases:6.86%
controls:4.10%
44
455
1422
13925
39
283
1434
14161
6
61
1467
14383
6
6
1467
14438
18
55
1454
14387
56
265
1407
14132
97
571
1316
13345
venlafaxine; oral
N06AX16 [21604745]
1.3e+00
1.4e+00
7.6e-01
—
1.1e+00
1.1e+00
9.9e-01
cases:2.66%
controls:0.73%
cases:1.63%
controls:0.42%
cases:0.34%
controls:0.16%
—
—
cases:0.41%
controls:0.13%
cases:1.37%
controls:0.47%
cases:3.68%
controls:1.39%
39
105
1427
14275
24
61
1449
14383
5
23
1468
14421
—
6
19
1466
14423
20
68
1443
14329
52
194
1361
13722
Depressive episode, unspecified
F32.9 [45571760]
1.2e+00
1.3e+00
1.4e+00
—
—
1.2e+00
1.1e+00
cases:2.25%
controls:0.70%
cases:1.22%
controls:0.35%
cases:0.34%
controls:0.08%
—
—
—
—
cases:1.23%
controls:0.38%
cases:4.18%
controls:1.44%
33
100
1433
14280
18
51
1455
14393
5
12
1468
14432
—
—
18
55
1445
14342
59
200
1354
13716
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
-9.8e-02
2.7e-01
2.0e-01
2.3e+00
1.1e+00
7.5e-01
5.2e-01
cases:2.93%
controls:3.23%
cases:2.58%
controls:1.97%
cases:0.54%
controls:0.44%
cases:0.41%
controls:0.04%
cases:1.22%
controls:0.39%
cases:3.96%
controls:1.91%
cases:6.94%
controls:4.25%
43
464
1423
13916
38
285
1435
14159
8
64
1465
14380
6
6
1467
14438
18
57
1454
14385
58
275
1405
14122
98
592
1315
13324
Monocytes [#/volume] in Blood
26484-6 [3001604]
-1.2e-01
2.5e-01
1.0e-01
2.3e+00
1.1e+00
7.4e-01
4.7e-01
cases:2.86%
controls:3.22%
cases:2.58%
controls:2.02%
cases:0.48%
controls:0.43%
cases:0.41%
controls:0.04%
cases:1.22%
controls:0.39%
cases:3.83%
controls:1.87%
cases:6.86%
controls:4.41%
42
463
1424
13917
38
292
1435
14152
7
62
1466
14382
6
6
1467
14438
18
57
1454
14385
56
269
1407
14128
97
613
1316
13303
Basophils [#/volume] in Blood
26444-0 [3006315]
-1.2e-01
2.5e-01
1.0e-01
2.3e+00
1.1e+00
7.4e-01
4.7e-01
cases:2.86%
controls:3.23%
cases:2.58%
controls:2.02%
cases:0.48%
controls:0.43%
cases:0.41%
controls:0.04%
cases:1.22%
controls:0.39%
cases:3.83%
controls:1.87%
cases:6.86%
controls:4.41%
42
464
1424
13916
38
292
1435
14152
7
62
1466
14382
6
6
1467
14438
18
57
1454
14385
56
269
1407
14128
97
614
1316
13302
Eosinophils [#/volume] in Blood
26449-9 [3013115]
-6.8e-02
2.3e-01
2.2e-01
2.1e+00
1.2e+00
7.6e-01
4.8e-01
cases:3.14%
controls:3.35%
cases:2.58%
controls:2.06%
cases:0.54%
controls:0.44%
cases:0.41%
controls:0.05%
cases:1.36%
controls:0.39%
cases:4.03%
controls:1.92%
cases:7.29%
controls:4.63%
46
482
1420
13898
38
298
1435
14146
8
63
1465
14381
6
7
1467
14437
20
57
1452
14385
59
277
1404
14120
103
645
1310
13271
pregabalin; oral
N02BF02 [955152]
9.9e-01
1.1e+00
1.2e+00
—
1.6e+00
1.2e+00
1.3e+00
cases:1.98%
controls:0.74%
cases:1.22%
controls:0.40%
cases:0.48%
controls:0.15%
—
—
cases:0.54%
controls:0.11%
cases:1.50%
controls:0.46%
cases:4.32%
controls:1.25%
29
107
1437
14273
18
58
1455
14386
7
21
1466
14423
—
8
16
1464
14426
22
66
1441
14331
61
174
1352
13742
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
-1.4e-01
2.3e-01
1.0e-01
2.3e+00
1.1e+00
7.1e-01
4.6e-01
cases:2.93%
controls:3.36%
cases:2.58%
controls:2.06%
cases:0.48%
controls:0.43%
cases:0.41%
controls:0.04%
cases:1.22%
controls:0.41%
cases:3.83%
controls:1.92%
cases:7.01%
controls:4.54%
43
483
1423
13897
38
297
1435
14147
7
62
1466
14382
6
6
1467
14438
18
59
1454
14383
56
276
1407
14121
99
632
1314
13284
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.7e-01
5.2e-01
1.2e+00
—
1.6e+00
7.7e-01
4.7e-01
cases:7.09%
controls:6.03%
cases:7.33%
controls:4.49%
cases:2.78%
controls:0.87%
—
—
cases:3.80%
controls:0.79%
cases:9.57%
controls:4.68%
cases:16.77%
controls:11.21%
104
867
1362
13513
108
648
1365
13796
41
125
1432
14319
—
56
114
1416
14328
140
674
1323
13723
237
1560
1176
12356
Pulmonary Disease
29 [38004472]
6.0e-01
8.1e-01
1.5e+00
—
1.3e+00
9.6e-01
6.2e-01
cases:4.30%
controls:2.41%
cases:2.58%
controls:1.17%
cases:1.02%
controls:0.22%
—
—
cases:0.61%
controls:0.17%
cases:3.01%
controls:1.17%
cases:6.02%
controls:3.33%
63
347
1403
14033
38
169
1435
14275
15
32
1458
14412
—
9
25
1463
14417
44
169
1419
14228
85
463
1328
13453
Normoblasts [#/volume] in Blood
715-3 [3021589]
-3.1e-01
-3.9e-03
3.4e-01
2.8e+00
1.2e+00
4.6e-01
4.5e-01
cases:2.05%
controls:2.77%
cases:2.17%
controls:2.18%
cases:0.68%
controls:0.48%
cases:0.54%
controls:0.03%
cases:1.43%
controls:0.43%
cases:3.08%
controls:1.97%
cases:6.09%
controls:3.96%
30
399
1436
13981
32
315
1441
14129
10
70
1463
14374
8
5
1465
14439
21
62
1451
14380
45
284
1418
14113
86
551
1327
13365
Sequelae of cerebral infarction
I69.3 [45533476]
1.6e+00
1.9e+00
—
—
—
2.4e+00
2.0e+00
cases:0.41%
controls:0.08%
cases:0.41%
controls:0.06%
—
—
—
—
—
—
cases:0.55%
controls:0.05%
cases:1.27%
controls:0.18%
6
12
1460
14368
6
9
1467
14435
—
—
—
8
7
1455
14390
18
25
1395
13891
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
4.6e-01
1.5e+00
2.1e+00
1.0e+50
1.8e+00
8.6e-01
7.0e-01
cases:1.50%
controls:0.95%
cases:1.77%
controls:0.39%
cases:0.61%
controls:0.08%
cases:0.61%
controls:0.00%
cases:0.34%
controls:0.06%
cases:1.03%
controls:0.44%
cases:3.18%
controls:1.60%
22
137
1444
14243
26
56
1447
14388
9
11
1464
14433
9
0
1464
14444
5
8
1467
14434
15
63
1448
14334
45
223
1368
13693
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
-4.4e-01
5.6e-01
1.7e+00
—
1.9e+00
6.4e-01
7.2e-01
cases:0.68%
controls:1.05%
cases:1.29%
controls:0.74%
cases:0.61%
controls:0.12%
—
—
cases:0.75%
controls:0.11%
cases:0.96%
controls:0.51%
cases:2.12%
controls:1.05%
10
151
1456
14229
19
107
1454
14337
9
17
1464
14427
—
11
16
1461
14426
14
73
1449
14324
30
146
1383
13770
Moderate panic disorder
F41.00 [2000501994]
2.2e+00
—
—
—
—
—
2.1e+00
cases:0.48%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.11%
7
8
1459
14372
—
—
—
—
—
12
15
1401
13901
Base excess in Venous blood by calculation
1927-3 [3002032]
-4.4e-01
5.7e-01
1.7e+00
—
1.8e+00
6.3e-01
7.0e-01
cases:0.68%
controls:1.05%
cases:1.29%
controls:0.73%
cases:0.61%
controls:0.12%
—
—
cases:0.68%
controls:0.11%
cases:0.96%
controls:0.51%
cases:2.05%
controls:1.03%
10
151
1456
14229
19
106
1454
14338
9
17
1464
14427
—
10
16
1462
14426
14
74
1449
14323
29
144
1384
13772
Fall into hole or other opening in surface
E883A [2000408881]
7.1e-01
—
—
—
—
2.1e+00
1.9e+00
cases:0.48%
controls:0.24%
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.05%
cases:0.85%
controls:0.12%
7
34
1459
14346
—
—
—
—
6
7
1457
14390
12
17
1401
13899
Neuropsychological evaluation of need and possibilities to rehabilitation
R1230 [2001310176]
1.9e+00
1.6e+00
—
—
—
—
2.1e+00
cases:0.48%
controls:0.07%
cases:0.34%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.14%
7
10
1459
14370
5
10
1468
14434
—
—
—
—
17
20
1396
13896
Monitored bed care
WX892 [2001310850]
1.1e+00
8.2e-01
—
—
—
2.3e+00
1.6e+00
cases:0.75%
controls:0.25%
cases:0.41%
controls:0.18%
—
—
—
—
—
—
cases:0.55%
controls:0.06%
cases:1.42%
controls:0.28%
11
36
1455
14344
6
26
1467
14418
—
—
—
8
8
1455
14389
20
39
1393
13877
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
3.6e-01
6.4e-01
1.3e+00
—
1.6e+00
4.5e-01
4.1e-01
cases:4.57%
controls:3.22%
cases:4.75%
controls:2.55%
cases:1.56%
controls:0.43%
—
—
cases:1.56%
controls:0.33%
cases:4.31%
controls:2.80%
cases:9.91%
controls:6.83%
67
463
1399
13917
70
369
1403
14075
23
62
1450
14382
—
23
48
1449
14394
63
403
1400
13994
140
951
1273
12965
Bipolar affective disorder, unspecified
F31.9 [45571758]
1.6e+00
1.9e+00
—
—
—
1.8e+00
2.1e+00
cases:0.55%
controls:0.11%
cases:0.41%
controls:0.06%
—
—
—
—
—
—
cases:0.55%
controls:0.09%
cases:0.99%
controls:0.12%
8
16
1458
14364
6
9
1467
14435
—
—
—
8
13
1455
14384
14
17
1399
13899
General medical examination, Routine general medical examination at a health care facility
V700A [2000409207]
1.5e+00
—
—
—
—
—
2.4e+00
cases:0.68%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.04%
10
23
1456
14357
—
—
—
—
—
7
6
1406
13910
sertraline; oral
N06AB06 [21604714]
1.0e+00
1.0e+00
—
—
1.2e+00
1.1e+00
7.2e-01
cases:1.57%
controls:0.58%
cases:1.15%
controls:0.41%
—
—
—
—
cases:0.34%
controls:0.10%
cases:1.23%
controls:0.40%
cases:2.83%
controls:1.40%
23
84
1443
14296
17
59
1456
14385
—
—
5
15
1467
14427
18
58
1445
14339
40
195
1373
13721
citalopram; oral, parenteral
N06AB04 [21604712]
9.7e-01
1.0e+00
8.5e-01
—
7.7e-01
8.7e-01
9.8e-01
cases:4.37%
controls:1.70%
cases:2.92%
controls:1.08%
cases:0.68%
controls:0.29%
—
—
cases:0.75%
controls:0.35%
cases:2.94%
controls:1.25%
cases:6.65%
controls:2.59%
64
244
1402
14136
43
156
1430
14288
10
42
1463
14402
—
11
50
1461
14392
43
180
1420
14217
94
361
1319
13555
Severe depressive episode with psychotic symptoms
F32.3 [45600739]
1.4e+00
—
—
—
—
2.1e+00
1.7e+00
cases:0.48%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.05%
cases:0.64%
controls:0.12%
7
17
1459
14363
—
—
—
—
6
7
1457
14390
9
17
1404
13899
thioridazine; oral
N05AC02 [21604512]
1.9e+00
2.1e+00
—
—
—
1.9e+00
1.9e+00
cases:0.55%
controls:0.08%
cases:0.34%
controls:0.04%
—
—
—
—
—
—
cases:0.41%
controls:0.06%
cases:0.78%
controls:0.12%
8
12
1458
14368
5
6
1468
14438
—
—
—
6
9
1457
14388
11
17
1402
13899
General symptoms, Convulsions
7803A [2000406893]
3.7e+00
1.0e+50
1.0e+50
—
1.0e+50
—
—
cases:2.18%
controls:0.06%
cases:1.97%
controls:0.00%
cases:0.61%
controls:0.00%
—
—
cases:0.48%
controls:0.00%
—
—
—
—
32
8
1434
14372
29
0
1444
14444
9
0
1464
14444
—
7
0
1465
14442
—
—
Anorexia nervosa
F50.0 [45562053]
1.9e+00
—
—
—
—
—
1.7e+00
cases:0.55%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.10%
8
12
1458
14368
—
—
—
—
—
8
14
1405
13902
Occupational therapy
R4120 [2001310234]
1.1e+00
1.5e+00
—
—
—
2.2e+00
1.4e+00
cases:0.61%
controls:0.22%
cases:0.41%
controls:0.09%
—
—
—
—
—
—
cases:0.55%
controls:0.06%
cases:1.13%
controls:0.27%
9
31
1457
14349
6
13
1467
14431
—
—
—
8
9
1455
14388
16
38
1397
13878
ECG with 12 standard connections
XF400 [2001303368]
8.9e-01
1.6e+00
—
—
-1.0e+50
6.4e-01
1.1e+00
cases:3.00%
controls:1.25%
cases:2.51%
controls:0.52%
—
—
—
—
cases:0.00%
controls:0.07%
cases:0.62%
controls:0.33%
cases:3.18%
controls:1.09%
44
180
1422
14200
37
75
1436
14369
—
—
0
10
1472
14432
9
47
1454
14350
45
152
1368
13764
Cathetrisation of vein
TPH04 [2001309597]
1.1e+00
1.6e+00
—
—
—
1.1e+00
9.3e-01
cases:2.25%
controls:0.79%
cases:1.29%
controls:0.27%
—
—
—
—
—
—
cases:0.68%
controls:0.22%
cases:2.69%
controls:1.08%
33
113
1433
14267
19
39
1454
14405
—
—
—
10
32
1453
14365
38
150
1375
13766
pH of Venous blood
2746-6 [3012544]
-4.4e-01
5.7e-01
1.7e+00
—
1.9e+00
6.4e-01
6.7e-01
cases:0.68%
controls:1.05%
cases:1.29%
controls:0.73%
cases:0.61%
controls:0.12%
—
—
cases:0.75%
controls:0.11%
cases:0.96%
controls:0.51%
cases:2.05%
controls:1.06%
10
151
1456
14229
19
106
1454
14338
9
17
1464
14427
—
11
16
1461
14426
14
73
1449
14324
29
148
1384
13768
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
-4.9e-01
6.2e-01
1.7e+00
—
1.9e+00
5.7e-01
7.1e-01
cases:0.61%
controls:1.00%
cases:1.29%
controls:0.70%
cases:0.61%
controls:0.12%
—
—
cases:0.68%
controls:0.10%
cases:0.82%
controls:0.47%
cases:1.91%
controls:0.95%
9
144
1457
14236
19
101
1454
14343
9
17
1464
14427
—
10
15
1462
14427
12
67
1451
14330
27
132
1386
13784
Migraine without aura [common migraine]
G43.0 [45600784]
7.9e-01
1.5e+00
—
1.0e+50
—
1.3e+00
8.2e-01
cases:1.02%
controls:0.47%
cases:1.09%
controls:0.26%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.82%
controls:0.24%
cases:1.91%
controls:0.85%
15
67
1451
14313
16
37
1457
14407
—
5
0
1468
14444
—
12
34
1451
14363
27
118
1386
13798
Recurrent depressive disorder, unspecified
F33.9 [45581458]
1.9e+00
—
—
—
—
—
1.6e+00
cases:0.48%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.19%
7
10
1459
14370
—
—
—
—
—
13
27
1400
13889
gabapentin; oral
N02BF01 [955005]
9.7e-01
1.3e+00
1.2e+00
—
1.5e+00
1.0e+00
1.2e+00
cases:1.30%
controls:0.49%
cases:0.95%
controls:0.26%
cases:0.34%
controls:0.10%
—
—
cases:0.34%
controls:0.08%
cases:0.96%
controls:0.35%
cases:2.48%
controls:0.77%
19
71
1447
14309
14
38
1459
14406
5
15
1468
14429
—
5
11
1467
14431
14
51
1449
14346
35
107
1378
13809
furosemide and potassium-sparing agents
C03EB01 [21601554]
1.4e+00
2.3e+00
—
—
—
1.3e+00
1.1e+00
cases:0.61%
controls:0.15%
cases:0.54%
controls:0.06%
—
—
—
—
—
—
cases:0.48%
controls:0.13%
cases:0.99%
controls:0.32%
9
21
1457
14359
8
8
1465
14436
—
—
—
7
18
1456
14379
14
44
1399
13872
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
2.4e+00
—
—
—
—
—
1.1e+00
cases:1.23%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.34%
18
17
1448
14363
—
—
—
—
—
14
48
1399
13868
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
4.0e-01
9.5e-01
1.3e+00
—
—
1.1e+00
1.2e+00
cases:1.71%
controls:1.15%
cases:1.15%
controls:0.45%
cases:0.34%
controls:0.10%
—
—
—
—
cases:1.09%
controls:0.36%
cases:4.81%
controls:1.43%
25
165
1441
14215
17
65
1456
14379
5
14
1468
14430
—
—
16
52
1447
14345
68
199
1345
13717
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
1.0e+00
1.2e+00
—
—
—
1.1e+00
8.8e-01
cases:1.16%
controls:0.43%
cases:0.81%
controls:0.24%
—
—
—
—
—
—
cases:0.82%
controls:0.26%
cases:2.12%
controls:0.89%
17
62
1449
14318
12
34
1461
14410
—
—
—
12
38
1451
14359
30
124
1383
13792
alprazolam; oral
N05BA12 [21604577]
1.3e+00
9.8e-01
1.3e+00
—
—
8.7e-01
8.4e-01
cases:2.25%
controls:0.62%
cases:1.22%
controls:0.46%
cases:0.48%
controls:0.13%
—
—
—
—
cases:0.89%
controls:0.38%
cases:2.26%
controls:0.99%
33
89
1433
14291
18
67
1455
14377
7
19
1466
14425
—
—
13
54
1450
14343
32
138
1381
13778
zopiclone; oral
N05CF01 [21604654]
8.1e-01
7.8e-01
7.2e-01
—
5.1e-01
7.2e-01
7.8e-01
cases:4.98%
controls:2.27%
cases:3.19%
controls:1.48%
cases:0.68%
controls:0.33%
—
—
cases:0.61%
controls:0.37%
cases:3.14%
controls:1.55%
cases:7.15%
controls:3.40%
73
327
1393
14053
47
214
1426
14230
10
48
1463
14396
—
9
53
1463
14389
46
223
1417
14174
101
473
1312
13443
Hospital outpatient
ZY010 [2001311599]
8.0e-01
8.4e-01
1.1e+00
—
1.3e+00
1.3e+00
1.8e+00
cases:0.95%
controls:0.43%
cases:0.54%
controls:0.24%
cases:0.34%
controls:0.11%
—
—
cases:0.34%
controls:0.10%
cases:0.75%
controls:0.21%
cases:1.91%
controls:0.32%
14
62
1452
14318
8
34
1465
14410
5
16
1468
14428
—
5
14
1467
14428
11
30
1452
14367
27
44
1386
13872
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
5.4e-01
1.3e+00
—
—
—
1.9e+00
1.2e+00
cases:0.48%
controls:0.28%
cases:0.54%
controls:0.15%
—
—
—
—
—
—
cases:0.82%
controls:0.13%
cases:1.49%
controls:0.47%
7
40
1459
14340
8
21
1465
14423
—
—
—
12
18
1451
14379
21
66
1392
13850
Physiotherapist
Z3226 [2001311560]
4.4e-01
8.7e-01
—
—
—
1.7e+00
1.3e+00
cases:2.39%
controls:1.55%
cases:1.09%
controls:0.46%
—
—
—
—
—
—
cases:1.44%
controls:0.28%
cases:3.61%
controls:1.03%
35
223
1431
14157
16
66
1457
14378
—
—
—
21
40
1442
14357
51
143
1362
13773
INR in Blood by Coagulation assay
34714-6 [3032080]
5.1e-01
6.2e-01
1.2e+00
—
1.4e+00
8.6e-01
6.5e-01
cases:2.18%
controls:1.33%
cases:1.63%
controls:0.89%
cases:0.75%
controls:0.23%
—
—
cases:0.68%
controls:0.17%
cases:1.50%
controls:0.64%
cases:3.54%
controls:1.88%
32
191
1434
14189
24
128
1449
14316
11
33
1462
14411
—
10
24
1462
14418
22
92
1441
14305
50
262
1363
13654
Unspecified fall
W19 [45756257]
5.5e-01
1.2e+00
—
—
—
1.8e+00
1.2e+00
cases:0.68%
controls:0.40%
cases:0.48%
controls:0.15%
—
—
—
—
—
—
cases:0.68%
controls:0.12%
cases:1.63%
controls:0.52%
10
57
1456
14323
7
21
1466
14423
—
—
—
10
17
1453
14380
23
72
1390
13844
Headache
R51.80 [2000503603]
8.0e-01
1.2e+00
—
—
—
9.0e-01
9.4e-01
cases:2.05%
controls:0.93%
cases:1.15%
controls:0.36%
—
—
—
—
—
—
cases:0.75%
controls:0.31%
cases:3.18%
controls:1.26%
30
134
1436
14246
17
52
1456
14392
—
—
—
11
44
1452
14353
45
176
1368
13740
Sequelae of intracranial injury
T90.5 [45537098]
—
—
—
—
—
—
2.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.04%
—
—
—
—
—
—
11
6
1402
13910
Person consulting for explanation of investigation findings
Z71.2 [45552100]
7.0e-01
1.0e-01
—
—
—
1.4e+00
8.3e-01
cases:2.05%
controls:1.03%
cases:0.54%
controls:0.49%
—
—
—
—
—
—
cases:1.57%
controls:0.41%
cases:4.03%
controls:1.80%
30
148
1436
14232
8
71
1465
14373
—
—
—
23
59
1440
14338
57
251
1356
13665
pH of Specimen
17433-4 [3019225]
2.8e-01
1.7e+00
—
—
—
1.0e+00
1.1e+00
cases:0.34%
controls:0.26%
cases:0.81%
controls:0.15%
—
—
—
—
—
—
cases:0.41%
controls:0.15%
cases:0.99%
controls:0.34%
5
37
1461
14343
12
21
1461
14423
—
—
—
6
21
1457
14376
14
47
1399
13869
MRI examination of brain with 3 Tesla magnet
AA1BM [2001300113]
—
—
—
1.0e+50
—
—
2.8e+00
—
—
—
—
—
—
cases:0.34%
controls:0.00%
—
—
—
—
cases:0.57%
controls:0.04%
—
—
—
5
0
1468
14444
—
—
8
5
1405
13911
fluoxetine; oral
N06AB03 [21604711]
1.1e+00
1.1e+00
—
—
1.3e+00
8.4e-01
5.9e-01
cases:2.93%
controls:1.01%
cases:1.49%
controls:0.52%
—
—
—
—
cases:0.41%
controls:0.11%
cases:1.37%
controls:0.60%
cases:2.90%
controls:1.63%
43
145
1423
14235
22
75
1451
14369
—
—
6
16
1466
14426
20
86
1443
14311
41
227
1372
13689
melatonin; oral
N05CH01 [21604659]
4.8e-01
5.2e-01
—
—
2.0e+00
5.5e-01
7.4e-01
cases:0.68%
controls:0.42%
cases:0.48%
controls:0.28%
—
—
—
—
cases:0.41%
controls:0.06%
cases:0.68%
controls:0.40%
cases:2.12%
controls:1.03%
10
61
1456
14319
7
41
1466
14403
—
—
6
8
1466
14434
10
57
1453
14340
30
143
1383
13773
Thorax X-ray examination
GD1AA [2001303617]
2.8e-01
7.3e-01
—
—
1.7e+00
9.8e-01
1.0e+00
cases:2.59%
controls:1.97%
cases:1.83%
controls:0.89%
—
—
—
—
cases:0.34%
controls:0.06%
cases:1.78%
controls:0.67%
cases:5.73%
controls:2.15%
38
283
1428
14097
27
129
1446
14315
—
—
5
9
1467
14433
26
97
1437
14300
81
299
1332
13617
biperiden; oral, parenteral
N04AA02 [21604447]
1.6e+00
—
—
—
—
—
2.7e+00
cases:0.41%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.07%
6
12
1460
14368
—
—
—
—
—
15
10
1398
13906
Supine thorax X-ray examination
GD1QA [2001303648]
1.4e+00
1.5e+00
—
—
—
—
1.3e+00
cases:0.82%
controls:0.21%
cases:0.48%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.49%
controls:0.40%
12
30
1454
14350
7
16
1466
14428
—
—
—
—
21
56
1392
13860
Schizophrenia, unspecified
F20.9 [45576533]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.13%
controls:0.08%
—
—
—
—
—
—
16
11
1397
13905
codeine and paracetamol
N02AJ06 [1123647]
3.6e-01
5.9e-01
8.7e-01
—
1.5e+00
7.9e-01
4.2e-01
cases:4.30%
controls:3.05%
cases:2.44%
controls:1.36%
cases:0.61%
controls:0.26%
—
—
cases:0.68%
controls:0.16%
cases:3.01%
controls:1.39%
cases:8.63%
controls:5.86%
63
438
1403
13942
36
197
1437
14247
9
37
1464
14407
—
10
23
1462
14419
44
200
1419
14197
122
816
1291
13100
propranolol; oral, parenteral
C07AA05 [21601670]
5.5e-01
5.9e-01
9.5e-01
—
1.8e+00
8.2e-01
4.5e-01
cases:3.00%
controls:1.76%
cases:1.77%
controls:0.99%
cases:0.34%
controls:0.13%
—
—
cases:0.82%
controls:0.13%
cases:2.12%
controls:0.94%
cases:4.39%
controls:2.85%
44
253
1422
14127
26
143
1447
14301
5
19
1468
14425
—
12
19
1460
14423
31
136
1432
14261
62
396
1351
13520
Migraine, unspecified
G43.9 [45595943]
7.7e-01
1.7e+00
—
—
—
8.2e-01
1.0e+00
cases:0.75%
controls:0.35%
cases:0.61%
controls:0.12%
—
—
—
—
—
—
cases:0.41%
controls:0.18%
cases:1.49%
controls:0.55%
11
50
1455
14330
9
17
1464
14427
—
—
—
6
26
1457
14371
21
77
1392
13839
More than one and less than three hours
ZXE10 [2001311401]
5.3e-01
7.3e-01
—
—
—
1.2e+00
9.6e-01
cases:4.02%
controls:2.41%
cases:1.49%
controls:0.73%
—
—
—
—
—
—
cases:1.78%
controls:0.57%
cases:6.16%
controls:2.44%
59
347
1407
14033
22
105
1451
14339
—
—
—
26
82
1437
14315
87
340
1326
13576
Moderate depressive episode with somatic syndrome
F32.11 [2000501981]
—
—
—
—
—
2.6e+00
1.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.48%
controls:0.03%
cases:0.64%
controls:0.22%
—
—
—
—
—
7
5
1456
14392
9
31
1404
13885
Pelvic and perineal pain
R10.2 [45548947]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.04%
—
—
—
—
—
—
8
6
1405
13910
Extensive CT of head and brain
AA1BD [2001300110]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.04%
—
—
—
—
—
—
8
6
1405
13910
Febrile convulsions
R56.0 [45606819]
2.6e+00
—
—
—
—
—
—
cases:0.55%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
8
6
1458
14374
—
—
—
—
—
—
Acute inflammatory disease of uterus
N71.0 [45596880]
2.6e+00
-1.0e+50
—
—
—
—
1.3e+00
cases:0.55%
controls:0.04%
cases:0.00%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.64%
controls:0.17%
8
6
1458
14374
0
6
1473
14438
—
—
—
—
9
24
1404
13892
Developmental disorder of scholastic skills, unspecified
F81.9 [45581474]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.64%
controls:0.05%
—
—
—
—
—
—
9
7
1404
13909
Other and unspecified abdominal pain
R10.4 [45568113]
3.1e-01
4.8e-01
—
—
2.0e+00
3.1e-01
5.5e-01
cases:4.02%
controls:2.98%
cases:1.70%
controls:1.05%
—
—
—
—
cases:0.54%
controls:0.08%
cases:1.50%
controls:1.11%
cases:6.72%
controls:3.98%
59
428
1407
13952
25
152
1448
14292
—
—
8
11
1464
14431
22
160
1441
14237
95
554
1318
13362
Physical Medicine And Rehabilitation
25 [38004468]
4.8e-01
5.0e-01
1.3e+00
1.0e+50
1.6e+00
8.4e-01
4.2e-01
cases:3.68%
controls:2.32%
cases:1.56%
controls:0.96%
cases:0.61%
controls:0.17%
cases:0.48%
controls:0.00%
cases:0.68%
controls:0.13%
cases:2.39%
controls:1.04%
cases:5.17%
controls:3.45%
54
333
1412
14047
23
138
1450
14306
9
24
1464
14420
7
0
1466
14444
10
19
1462
14423
35
150
1428
14247
73
480
1340
13436
Flail joint
M25.2 [45567527]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.04%
—
—
—
—
—
—
6
5
1407
13911
Counselling and guidance which enhance independent living
R2130 [2001310196]
6.4e-01
7.2e-01
—
1.0e+50
—
1.3e+00
1.1e+00
cases:1.50%
controls:0.80%
cases:0.61%
controls:0.30%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.09%
controls:0.30%
cases:2.41%
controls:0.78%
22
115
1444
14265
9
43
1464
14401
—
5
0
1468
14444
—
16
43
1447
14354
34
108
1379
13808
furosemide; oral, parenteral
C03CA01 [21601518]
7.6e-01
7.8e-01
1.0e+00
—
4.9e-01
6.0e-01
9.0e-01
cases:2.18%
controls:1.03%
cases:1.56%
controls:0.72%
cases:0.54%
controls:0.19%
—
—
cases:0.34%
controls:0.21%
cases:1.50%
controls:0.83%
cases:3.89%
controls:1.62%
32
148
1434
14232
23
104
1450
14340
8
28
1465
14416
—
5
30
1467
14412
22
120
1441
14277
55
226
1358
13690
Open wound of scalp
S01.0 [45592468]
1.4e+00
—
—
—
—
—
1.0e+00
cases:0.68%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.36%
10
24
1456
14356
—
—
—
—
—
14
50
1399
13866
FEV1
20150-9 [3024653]
1.1e+00
5.6e-01
—
—
—
1.3e+00
1.4e+00
cases:1.43%
controls:0.49%
cases:0.34%
controls:0.19%
—
—
—
—
—
—
cases:0.62%
controls:0.17%
cases:1.84%
controls:0.48%
21
71
1445
14309
5
28
1468
14416
—
—
—
9
24
1454
14373
26
67
1387
13849
FEV1/FVC
19926-5 [3011505]
1.1e+00
5.6e-01
—
—
—
1.3e+00
1.4e+00
cases:1.43%
controls:0.49%
cases:0.34%
controls:0.19%
—
—
—
—
—
—
cases:0.62%
controls:0.17%
cases:1.84%
controls:0.48%
21
71
1445
14309
5
28
1468
14416
—
—
—
9
24
1454
14373
26
67
1387
13849
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.1e+00
5.6e-01
—
—
—
1.3e+00
1.4e+00
cases:1.43%
controls:0.49%
cases:0.34%
controls:0.19%
—
—
—
—
—
—
cases:0.62%
controls:0.17%
cases:1.84%
controls:0.48%
21
71
1445
14309
5
28
1468
14416
—
—
—
9
24
1454
14373
26
67
1387
13849
Secondary oligomenorrhoea
N91.4 [45534148]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.05%
—
—
—
—
—
—
8
7
1405
13909
Dizziness and giddiness
R42 [45568132]
6.4e-01
1.6e+00
—
—
—
9.8e-01
7.5e-01
cases:1.36%
controls:0.72%
cases:1.09%
controls:0.21%
—
—
—
—
—
—
cases:0.75%
controls:0.28%
cases:2.26%
controls:1.08%
20
104
1446
14276
16
31
1457
14413
—
—
—
11
41
1452
14356
32
150
1381
13766
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
9.8e-01
9.3e-01
—
—
—
1.2e+00
1.4e+00
cases:1.16%
controls:0.44%
cases:0.54%
controls:0.21%
—
—
—
—
—
—
cases:0.62%
controls:0.18%
cases:2.26%
controls:0.59%
17
63
1449
14317
8
31
1465
14413
—
—
—
9
26
1454
14371
32
82
1381
13834
escitalopram; oral
N06AB10 [21604718]
8.2e-01
8.3e-01
7.8e-01
—
5.9e-01
7.3e-01
7.0e-01
cases:2.86%
controls:1.29%
cases:2.04%
controls:0.90%
cases:0.41%
controls:0.19%
—
—
cases:0.48%
controls:0.26%
cases:1.78%
controls:0.87%
cases:4.67%
controls:2.38%
42
185
1424
14195
30
130
1443
14314
6
27
1467
14417
—
7
38
1465
14404
26
125
1437
14272
66
331
1347
13585
Lichen simplex chronicus
L28.0 [45577032]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.04%
—
—
—
—
—
—
6
6
1407
13910
Open wound of ear
S01.3 [45553789]
-1.0e+50
—
—
—
—
—
2.3e+00
cases:0.00%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.04%
0
5
1466
14375
—
—
—
—
—
6
6
1407
13910
Alcohol intoxication UNS
F10.09 [2000501676]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.04%
—
—
—
—
—
—
—
6
6
1457
14391
—
Recurrent depression, mild episode without somatic syndrome
F33.00 [2000501982]
2.3e+00
—
—
—
—
2.0e+00
1.4e+00
cases:0.48%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.34%
controls:0.05%
cases:0.42%
controls:0.10%
7
7
1459
14373
—
—
—
—
5
7
1458
14390
6
14
1407
13902
Unspecified mood [affective] disorder
F39 [45591137]
2.3e+00
—
—
—
—
—
1.2e+00
cases:0.48%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.13%
7
7
1459
14373
—
—
—
—
—
6
18
1407
13898
Bacterial infection, unspecified
A49.9 [45590816]
8.2e-01
2.3e+00
—
—
—
1.5e+00
1.1e+00
cases:0.41%
controls:0.18%
cases:0.41%
controls:0.04%
—
—
—
—
—
—
cases:0.34%
controls:0.08%
cases:0.92%
controls:0.32%
6
26
1460
14354
6
6
1467
14438
—
—
—
5
11
1458
14386
13
45
1400
13871
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
7.2e-01
8.7e-01
-1.0e+50
—
—
4.6e-01
6.9e-01
cases:1.91%
controls:0.94%
cases:1.36%
controls:0.57%
cases:0.00%
controls:0.06%
—
—
—
—
cases:0.82%
controls:0.52%
cases:4.18%
controls:2.14%
28
135
1438
14245
20
83
1453
14361
0
9
1473
14435
—
—
12
75
1451
14322
59
298
1354
13618
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
-3.4e-01
4.5e-01
1.4e+00
—
1.3e+00
8.7e-01
6.9e-01
cases:0.61%
controls:0.86%
cases:1.22%
controls:0.78%
cases:0.68%
controls:0.17%
—
—
cases:0.48%
controls:0.12%
cases:1.30%
controls:0.55%
cases:1.70%
controls:0.86%
9
124
1457
14256
18
113
1455
14331
10
25
1463
14419
—
7
18
1465
14424
19
79
1444
14318
24
120
1389
13796
12 lead EKG panel
34534-8 [3044889]
8.2e-02
5.2e-01
—
—
2.2e+00
3.8e-01
2.8e-01
cases:2.59%
controls:2.39%
cases:2.04%
controls:1.22%
—
—
—
—
cases:0.95%
controls:0.10%
cases:1.91%
controls:1.32%
cases:5.73%
controls:4.38%
38
344
1428
14036
30
176
1443
14268
—
—
14
15
1458
14427
28
190
1435
14207
81
609
1332
13307
Mixed anxiety and depressive disorder
F41.2 [45566845]
1.0e+00
1.1e+00
—
—
—
9.8e-01
1.2e+00
cases:1.02%
controls:0.37%
cases:0.61%
controls:0.20%
—
—
—
—
—
—
cases:0.68%
controls:0.26%
cases:2.55%
controls:0.80%
15
53
1451
14327
9
29
1464
14415
—
—
—
10
37
1453
14360
36
111
1377
13805
Lumbar puncture
TAB00 [2001300538]
8.8e-01
2.2e+00
—
—
—
—
8.5e-01
cases:0.82%
controls:0.34%
cases:0.68%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.15%
12
49
1454
14331
10
11
1463
14433
—
—
—
—
5
21
1408
13895
Specific developmental disorder of motor function
F82 [45605516]
2.2e+00
—
—
—
—
—
—
cases:0.61%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
9
10
1457
14370
—
—
—
—
—
—
Secondary amenorrhoea
N91.1 [45601758]
—
—
—
—
—
2.2e+00
9.3e-01
—
—
—
—
—
—
—
—
—
—
cases:0.55%
controls:0.06%
cases:0.71%
controls:0.28%
—
—
—
—
—
8
9
1455
14388
10
39
1403
13877
Transient cerebral ischaemic attack, unspecified
G45.9 [45542892]
2.2e+00
—
—
—
—
—
—
cases:0.55%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
8
9
1458
14371
—
—
—
—
—
—
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
1.3e+00
—
—
—
—
—
2.2e+00
cases:0.34%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.11%
5
14
1461
14366
—
—
—
—
—
14
16
1399
13900
Undifferentiated schizophrenia continuous
F20.30 [2000501944]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.06%
—
—
—
—
—
—
7
8
1406
13908
EEG
XA400 [2001300404]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.05%
—
—
—
—
—
—
6
7
1407
13909
Polyneuropathy, unspecified
G62.9 [45566898]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.05%
—
—
—
—
—
—
6
7
1407
13909
calcium (different salts in combination); oral
A12AA20 [21600872]
7.6e-01
6.9e-01
9.3e-01
—
2.0e-01
3.9e-01
6.8e-01
cases:3.27%
controls:1.56%
cases:2.17%
controls:1.10%
cases:0.61%
controls:0.24%
—
—
cases:0.34%
controls:0.28%
cases:1.91%
controls:1.30%
cases:4.81%
controls:2.49%
48
224
1418
14156
32
159
1441
14285
9
35
1464
14409
—
5
40
1467
14402
28
187
1435
14210
68
347
1345
13569
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
4939X [2000403998]
2.1e+00
—
—
—
—
—
—
cases:0.41%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
1460
14373
—
—
—
—
—
—
Pneumonia, unspecified
J18.9 [45601123]
7.5e-01
6.8e-01
—
—
—
1.1e+00
1.0e+00
cases:1.64%
controls:0.78%
cases:0.68%
controls:0.35%
—
—
—
—
—
—
cases:0.96%
controls:0.33%
cases:3.68%
controls:1.34%
24
112
1442
14268
10
50
1463
14394
—
—
—
14
47
1449
14350
52
187
1361
13729
Pain localized to other parts of lower abdomen
R10.3 [45534426]
5.1e-01
3.5e-01
—
—
—
1.4e+00
7.4e-01
cases:1.98%
controls:1.20%
cases:0.61%
controls:0.43%
—
—
—
—
—
—
cases:1.23%
controls:0.32%
cases:3.68%
controls:1.79%
29
173
1437
14207
9
62
1464
14382
—
—
—
18
46
1445
14351
52
249
1361
13667
General Surgery
2 [38004447]
4.3e-01
5.8e-01
8.1e-01
—
8.3e-01
4.8e-01
6.0e-01
cases:19.24%
controls:13.37%
cases:7.60%
controls:4.40%
cases:1.15%
controls:0.52%
—
—
cases:1.36%
controls:0.60%
cases:7.38%
controls:4.69%
cases:24.06%
controls:14.82%
282
1922
1184
12458
112
635
1361
13809
17
75
1456
14369
—
20
86
1452
14356
108
675
1355
13722
340
2063
1073
11853
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
7.4e-01
1.4e+00
—
—
—
1.6e-01
7.3e-01
cases:0.68%
controls:0.33%
cases:0.88%
controls:0.23%
—
—
—
—
—
—
cases:0.34%
controls:0.29%
cases:2.48%
controls:1.21%
10
47
1456
14333
13
33
1460
14411
—
—
—
5
42
1458
14355
35
169
1378
13747
trimipramine; oral, parenteral
N06AA06 [21604693]
2.0e+00
—
—
—
—
—
1.5e+00
cases:0.48%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.13%
7
9
1459
14371
—
—
—
—
—
8
18
1405
13898
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
1.1e+00
1.1e+00
—
—
—
2.0e+00
4.1e-01
cases:0.34%
controls:0.11%
cases:0.41%
controls:0.14%
—
—
—
—
—
—
cases:0.68%
controls:0.09%
cases:0.64%
controls:0.42%
5
16
1461
14364
6
20
1467
14424
—
—
—
10
13
1453
14384
9
59
1404
13857
Sytologyspecimen from mouth of uterus
XLD00 [2001306651]
1.1e+00
8.3e-01
—
—
—
9.8e-01
9.3e-01
cases:1.30%
controls:0.44%
cases:0.48%
controls:0.21%
—
—
—
—
—
—
cases:0.48%
controls:0.18%
cases:2.26%
controls:0.91%
19
63
1447
14317
7
30
1466
14414
—
—
—
7
26
1456
14371
32
126
1381
13790
pH of Arterial blood
2744-1 [3019977]
9.4e-01
1.1e+00
—
—
—
2.0e+00
4.4e-01
cases:0.41%
controls:0.16%
cases:0.54%
controls:0.19%
—
—
—
—
—
—
cases:0.82%
controls:0.11%
cases:0.78%
controls:0.50%
6
23
1460
14357
8
27
1465
14417
—
—
—
12
16
1451
14381
11
70
1402
13846
Procedure duration 120 to 149 minutes
ZXE15 [2001311406]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.06%
—
—
—
—
—
—
6
8
1407
13908
Conventional respirator
WX730 [2001310831]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.06%
—
—
—
—
—
—
6
8
1407
13908
Examination and observation following other accident
Z04.3 [45561609]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.06%
—
—
—
—
—
—
6
8
1407
13908
Open reduction and osteosynthesis
9128 [2000101435]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.06%
—
—
—
—
—
—
6
8
1407
13908
lactulose; oral
A06AD11 [21600571]
8.9e-01
6.8e-01
—
—
—
1.0e+00
1.1e+00
cases:1.30%
controls:0.54%
cases:0.41%
controls:0.21%
—
—
—
—
—
—
cases:0.68%
controls:0.25%
cases:1.98%
controls:0.66%
19
77
1447
14303
6
30
1467
14414
—
—
—
10
36
1453
14361
28
92
1385
13824
Dysthymia
F34.1 [45586238]
—
—
—
—
—
2.0e+00
1.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.06%
cases:0.71%
controls:0.25%
—
—
—
—
—
6
8
1457
14389
10
35
1403
13881
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
—
2.0e+00
—
—
—
—
5.2e-01
—
—
cases:0.61%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.29%
—
9
12
1464
14432
—
—
—
—
7
41
1406
13875
Unknown and unspecified causes of morbidity
R69 [45558480]
2.0e+00
—
—
—
—
—
—
cases:0.41%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
1460
14372
—
—
—
—
—
—
Fitting and adjustment of other specified devices
Z46.8 [45581035]
2.0e+00
—
—
—
—
-1.0e+50
—
cases:0.41%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.05%
—
—
6
8
1460
14372
—
—
—
—
0
7
1463
14390
—
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
5.8e-01
8.2e-01
—
—
—
1.2e+00
7.9e-01
cases:2.46%
controls:1.38%
cases:1.15%
controls:0.51%
—
—
—
—
—
—
cases:1.50%
controls:0.47%
cases:4.60%
controls:2.13%
36
199
1430
14181
17
74
1456
14370
—
—
—
22
67
1441
14330
65
297
1348
13619
Outcome of delivery
Z37 [45581024]
-2.9e-01
-6.4e-01
—
1.0e+50
2.0e+00
-1.7e-01
-9.0e-02
cases:4.77%
controls:6.26%
cases:0.95%
controls:1.79%
—
—
cases:0.41%
controls:0.00%
cases:1.22%
controls:0.17%
cases:1.71%
controls:2.02%
cases:6.65%
controls:7.24%
70
900
1396
13480
14
258
1459
14186
—
6
0
1467
14444
18
25
1454
14417
25
291
1438
14106
94
1007
1319
12909
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
9.9e-01
1.1e+00
—
—
—
1.9e+00
5.6e-01
cases:0.41%
controls:0.15%
cases:0.54%
controls:0.18%
—
—
—
—
—
—
cases:0.82%
controls:0.12%
cases:0.85%
controls:0.49%
6
22
1460
14358
8
26
1465
14418
—
—
—
12
17
1451
14380
12
68
1401
13848
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
9.9e-01
1.1e+00
—
—
—
1.9e+00
5.6e-01
cases:0.41%
controls:0.15%
cases:0.54%
controls:0.18%
—
—
—
—
—
—
cases:0.82%
controls:0.12%
cases:0.85%
controls:0.49%
6
22
1460
14358
8
26
1465
14418
—
—
—
12
17
1451
14380
12
68
1401
13848
Emergency Room and Inpatient Visit
ERIP [262]
5.0e-01
1.0e+00
—
1.0e+50
—
9.2e-01
5.4e-01
cases:1.16%
controls:0.71%
cases:1.43%
controls:0.52%
—
—
cases:0.68%
controls:0.00%
—
—
cases:1.37%
controls:0.55%
cases:3.04%
controls:1.79%
17
102
1449
14278
21
75
1452
14369
—
10
0
1463
14444
—
20
79
1443
14318
43
249
1370
13667
Sleep disorder, unspecified
G47.9 [45595948]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.07%
—
—
—
—
—
—
7
10
1406
13906
Social problem NOS
Z29 [2002001483]
1.9e+00
—
—
—
—
—
—
cases:0.48%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
7
10
1459
14370
—
—
—
—
—
—
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
4.6e-01
8.3e-01
9.3e-01
—
6.8e-01
5.9e-01
5.1e-01
cases:3.96%
controls:2.53%
cases:3.12%
controls:1.39%
cases:0.61%
controls:0.24%
—
—
cases:0.41%
controls:0.21%
cases:2.80%
controls:1.57%
cases:8.78%
controls:5.48%
58
364
1408
14016
46
201
1427
14243
9
35
1464
14409
—
6
30
1466
14412
41
226
1422
14171
124
763
1289
13153
Concussion
S06.0 [45582805]
9.0e-01
1.3e+00
—
—
-1.0e+50
1.2e+00
9.9e-01
cases:1.23%
controls:0.50%
cases:0.61%
controls:0.16%
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.68%
controls:0.22%
cases:2.34%
controls:0.88%
18
72
1448
14308
9
23
1464
14421
—
—
0
5
1472
14437
10
31
1453
14366
33
122
1380
13794
Hemolysis interference index of Serum or Plasma
46424-8 [3052851]
8.6e-02
—
—
—
—
—
1.9e+00
cases:0.34%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.11%
5
45
1461
14335
—
—
—
—
—
10
15
1403
13901
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
4859X [2000403973]
1.9e+00
—
—
—
—
—
—
cases:0.55%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
8
12
1458
14368
—
—
—
—
—
—
Physiotherapy
R4110 [2001310233]
4.3e-01
6.6e-01
1.4e+00
—
1.5e+00
8.3e-01
1.0e+00
cases:2.39%
controls:1.57%
cases:1.43%
controls:0.74%
cases:0.54%
controls:0.13%
—
—
cases:0.41%
controls:0.09%
cases:1.57%
controls:0.69%
cases:4.81%
controls:1.77%
35
226
1431
14154
21
107
1452
14337
8
19
1465
14425
—
6
13
1466
14429
23
100
1440
14297
68
247
1345
13669
Skin, Repair/fix-suture/cast/prosth device
S54 [2002001018]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.08%
—
—
—
—
—
—
7
11
1406
13905
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
3.2e-02
3.2e-01
7.8e-01
—
—
1.0e+00
7.9e-01
cases:1.36%
controls:1.32%
cases:1.22%
controls:0.89%
cases:0.41%
controls:0.19%
—
—
—
—
cases:1.64%
controls:0.58%
cases:3.33%
controls:1.53%
20
190
1446
14190
18
129
1455
14315
6
27
1467
14417
—
—
24
84
1439
14313
47
213
1366
13703
Speech therapy
Z50.5 [45547321]
1.8e+00
—
—
—
—
—
—
cases:0.82%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
12
19
1454
14361
—
—
—
—
—
—
Base excess in Arterial blood by calculation
1925-7 [3003396]
9.9e-01
1.1e+00
—
—
—
1.8e+00
4.7e-01
cases:0.41%
controls:0.15%
cases:0.54%
controls:0.18%
—
—
—
—
—
—
cases:0.68%
controls:0.11%
cases:0.78%
controls:0.49%
6
22
1460
14358
8
26
1465
14418
—
—
—
10
16
1453
14381
11
68
1402
13848
Cervical spine CT examination
NA1AD [2001306982]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.09%
—
—
—
—
—
—
8
13
1405
13903
Recurrent dislocation and subluxation of joint
M24.4 [45557843]
—
-1.0e+50
—
—
—
—
1.8e+00
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.09%
—
0
7
1473
14437
—
—
—
—
8
13
1405
13903
Hypo-osmolality and hyponatraemia
E87.1 [45542779]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.10%
—
—
—
—
—
—
8
14
1405
13902
Urine symptom/complaint other
U07 [2002001142]
1.7e+00
—
—
—
—
—
1.4e+00
cases:0.55%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.64%
controls:0.17%
8
14
1458
14366
—
—
—
—
—
9
23
1404
13893
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
-4.1e-01
3.8e-01
1.7e+00
—
—
9.5e-01
7.1e-01
cases:0.61%
controls:0.92%
cases:0.88%
controls:0.60%
cases:0.54%
controls:0.10%
—
—
—
—
cases:0.82%
controls:0.32%
cases:1.06%
controls:0.52%
9
133
1457
14247
13
87
1460
14357
8
14
1465
14430
—
—
12
46
1451
14351
15
73
1398
13843
Other specified counselling
Z71.8 [45581061]
-2.6e-02
2.2e-01
—
—
1.7e+00
1.2e+00
5.6e-01
cases:1.02%
controls:1.05%
cases:0.68%
controls:0.55%
—
—
—
—
cases:0.34%
controls:0.06%
cases:1.50%
controls:0.48%
cases:4.39%
controls:2.55%
15
151
1451
14229
10
79
1463
14365
—
—
5
9
1467
14433
22
69
1441
14328
62
355
1351
13561
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
1.7e+00
1.7e+00
—
—
—
—
1.4e+00
cases:0.61%
controls:0.11%
cases:0.34%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.64%
controls:0.17%
9
16
1457
14364
5
9
1468
14435
—
—
—
—
9
23
1404
13893
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
-3.5e-01
5.4e-01
1.7e+00
—
—
9.8e-01
7.7e-01
cases:0.75%
controls:1.06%
cases:1.15%
controls:0.68%
cases:0.68%
controls:0.12%
—
—
—
—
cases:1.03%
controls:0.39%
cases:1.49%
controls:0.70%
11
153
1455
14227
17
98
1456
14346
10
18
1463
14426
—
—
15
56
1448
14341
21
97
1392
13819
UNS Panic Syndrome
F41.09 [2000501997]
1.1e+00
—
—
—
—
2.1e+00
1.7e+00
cases:0.48%
controls:0.16%
—
—
—
—
—
—
—
—
cases:0.34%
controls:0.04%
cases:1.20%
controls:0.22%
7
23
1459
14357
—
—
—
—
5
6
1458
14391
17
31
1396
13885
Cutaneous abscess, furuncle and carbuncle, unspecified
L02.9 [45591620]
-1.0e+50
—
—
—
—
—
1.7e+00
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.11%
0
9
1466
14371
—
—
—
—
—
8
15
1405
13901
Oxygen saturation in Arterial blood
2708-6 [3016502]
9.0e-01
7.8e-01
—
—
—
1.7e+00
4.2e-01
cases:0.34%
controls:0.14%
cases:0.41%
controls:0.19%
—
—
—
—
—
—
cases:0.55%
controls:0.10%
cases:0.71%
controls:0.47%
5
20
1461
14360
6
27
1467
14417
—
—
—
8
15
1455
14382
10
65
1403
13851
Contusion of elbow
S50.0 [45597855]
—
-1.0e+50
—
—
—
—
1.7e+00
—
—
cases:0.00%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.64%
controls:0.12%
—
0
5
1473
14439
—
—
—
—
9
17
1404
13899
theophylline; oral, parenteral, rectal
R03DA04 [21603332]
1.0e+00
1.3e+00
—
—
—
1.7e+00
8.3e-01
cases:0.55%
controls:0.19%
cases:0.48%
controls:0.12%
—
—
—
—
—
—
cases:0.68%
controls:0.13%
cases:0.85%
controls:0.37%
8
28
1458
14352
7
18
1466
14426
—
—
—
10
19
1453
14378
12
52
1401
13864
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
-3.5e-01
5.2e-01
1.6e+00
—
—
9.4e-01
7.9e-01
cases:0.75%
controls:1.06%
cases:1.15%
controls:0.69%
cases:0.68%
controls:0.13%
—
—
—
—
cases:1.03%
controls:0.40%
cases:1.56%
controls:0.71%
11
153
1455
14227
17
100
1456
14344
10
19
1463
14425
—
—
15
58
1448
14339
22
99
1391
13817
pH of Capillary blood
2745-8 [3009343]
-3.5e-01
5.2e-01
1.6e+00
—
—
9.6e-01
7.4e-01
cases:0.75%
controls:1.06%
cases:1.15%
controls:0.69%
cases:0.68%
controls:0.13%
—
—
—
—
cases:1.03%
controls:0.40%
cases:1.49%
controls:0.71%
11
153
1455
14227
17
100
1456
14344
10
19
1463
14425
—
—
15
57
1448
14340
21
99
1392
13817
Knee and lower leg MRI examination with high intensity magnet
NG1BG [2001308056]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.21%
—
—
—
—
—
—
15
29
1398
13887
Addiction caused by alcohol UNS
F10.29 [2000501684]
1.8e+00
—
—
—
—
—
1.6e+00
cases:0.34%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.17%
5
8
1461
14372
—
—
—
—
—
12
24
1401
13892
Mental disorder, not otherwise specified
F99 [45605525]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.16%
—
—
—
—
—
—
11
22
1402
13894
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
F79.0 [45566855]
1.8e+00
-1.0e+50
—
—
—
—
1.6e+00
cases:0.41%
controls:0.07%
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.14%
6
10
1460
14370
0
12
1473
14432
—
—
—
—
10
20
1403
13896
Panic disorder [episodic paroxysmal anxiety]
F41.0 [45562047]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.14%
—
—
—
—
—
—
10
20
1403
13896
Observation for suspected mental and behavioural disorders
Z03.2 [45552060]
9.4e-01
1.7e+00
—
—
—
—
1.6e+00
cases:0.48%
controls:0.19%
cases:0.34%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.14%
7
27
1459
14353
5
9
1468
14435
—
—
—
—
10
20
1403
13896
buprenorphine; implant, parenteral, sublingual
N07BC01 [21604826]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.11%
—
—
—
—
—
—
8
16
1405
13900
Mixed specific developmental disorders
F83 [45595922]
7.5e-01
8.2e-01
—
—
—
1.6e+00
1.2e+00
cases:0.55%
controls:0.26%
cases:0.41%
controls:0.18%
—
—
—
—
—
—
cases:0.62%
controls:0.13%
cases:0.57%
controls:0.17%
8
37
1458
14343
6
26
1467
14418
—
—
—
9
18
1454
14379
8
23
1405
13893
Dorsalgia
M54 [45553203]
1.6e+00
—
—
—
—
—
8.7e-01
cases:0.82%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.36%
12
24
1454
14356
—
—
—
—
—
12
50
1401
13866
Telephone prescription or other care instructions
WZB00 [2001310884]
2.9e-01
2.5e-01
-1.0e+50
—
—
9.5e-01
6.3e-01
cases:1.84%
controls:1.38%
cases:0.81%
controls:0.64%
cases:0.00%
controls:0.03%
—
—
—
—
cases:1.44%
controls:0.56%
cases:4.46%
controls:2.43%
27
199
1439
14181
12
92
1461
14352
0
5
1473
14439
—
—
21
81
1442
14316
63
338
1350
13578
econazole
D01AC03 [21601922]
5.9e-01
1.5e+00
—
—
—
—
7.0e-01
cases:0.89%
controls:0.49%
cases:0.68%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.60%
13
71
1453
14309
10
21
1463
14423
—
—
—
—
17
84
1396
13832
econazole; vaginal
G01AF05 [21602395]
6.0e-01
1.5e+00
—
—
—
—
8.3e-01
cases:0.95%
controls:0.53%
cases:0.68%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.42%
controls:0.63%
14
76
1452
14304
10
21
1463
14423
—
—
—
—
20
87
1393
13829
Medical observation and evaluation for suspected diseases and conditions, ruled out
Z03 [45552058]
—
—
—
—
—
1.4e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.10%
cases:1.34%
controls:0.29%
—
—
—
—
—
6
14
1457
14383
19
41
1394
13875
Abdominal ultrasound examination
JN3AE [2001305555]
-1.9e-02
2.6e-01
—
—
-1.0e+50
1.5e+00
3.5e-01
cases:0.82%
controls:0.83%
cases:0.48%
controls:0.37%
—
—
—
—
cases:0.00%
controls:0.04%
cases:1.03%
controls:0.23%
cases:1.27%
controls:0.90%
12
120
1454
14260
7
53
1466
14391
—
—
0
6
1472
14436
15
33
1448
14364
18
125
1395
13791
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
2.3e-01
9.5e-01
—
—
—
1.3e+00
1.5e+00
cases:0.34%
controls:0.27%
cases:0.34%
controls:0.13%
—
—
—
—
—
—
cases:0.48%
controls:0.13%
cases:1.63%
controls:0.37%
5
39
1461
14341
5
19
1468
14425
—
—
—
7
19
1456
14378
23
51
1390
13865
Dislocation of shoulder joint
S43.0 [45573622]
1.3e+00
1.6e+00
—
—
—
—
1.5e+00
cases:0.41%
controls:0.11%
cases:0.41%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.22%
6
16
1460
14364
6
12
1467
14432
—
—
—
—
14
31
1399
13885
Adaptation disorder with mixed anxiety and depression
F43.22 [2000502003]
1.1e+00
1.8e+00
—
—
—
1.7e+00
1.5e+00
cases:0.55%
controls:0.19%
cases:0.34%
controls:0.06%
—
—
—
—
—
—
cases:0.41%
controls:0.08%
cases:0.99%
controls:0.22%
8
27
1458
14353
5
8
1468
14436
—
—
—
6
11
1457
14386
14
31
1399
13885
Polyuria
R35 [45539331]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.64%
controls:0.14%
—
—
—
—
—
—
9
20
1404
13896
oxycodone; oral, parenteral
N02AA05 [21604260]
1.5e+00
1.3e+00
—
—
—
7.6e-01
3.4e-01
cases:0.61%
controls:0.14%
cases:0.48%
controls:0.12%
—
—
—
—
—
—
cases:0.34%
controls:0.16%
cases:0.71%
controls:0.50%
9
20
1457
14360
7
18
1466
14426
—
—
—
5
23
1458
14374
10
70
1403
13846
Catheterisation of bladder
TKC20 [2001306020]
1.5e+00
-1.0e+50
—
—
—
—
1.4e+00
cases:0.61%
controls:0.14%
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.14%
9
20
1457
14360
0
7
1473
14437
—
—
—
—
8
20
1405
13896
Otolaryngology
4 [38004449]
3.0e-01
4.8e-01
4.0e-01
—
3.9e-01
5.2e-01
4.8e-01
cases:9.55%
controls:7.23%
cases:4.14%
controls:2.61%
cases:0.48%
controls:0.32%
—
—
cases:0.61%
controls:0.42%
cases:4.31%
controls:2.60%
cases:11.82%
controls:7.62%
140
1040
1326
13340
61
377
1412
14067
7
46
1466
14398
—
9
60
1463
14382
63
375
1400
14022
167
1061
1246
12855
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2.5e-01
1.1e+00
1.8e+00
—
—
1.5e+00
7.7e-01
cases:0.41%
controls:0.32%
cases:0.75%
controls:0.24%
cases:0.34%
controls:0.06%
—
—
—
—
cases:0.75%
controls:0.17%
cases:1.20%
controls:0.56%
6
46
1460
14334
11
35
1462
14409
5
8
1468
14436
—
—
11
25
1452
14372
17
78
1396
13838
buspirone; oral
N05BE01 [21604601]
1.5e+00
—
—
—
—
2.3e+00
1.5e+00
cases:0.55%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.34%
controls:0.03%
cases:0.71%
controls:0.17%
8
17
1458
14363
—
—
—
—
5
5
1458
14392
10
23
1403
13893
Contusion of thorax
S20.2 [45597402]
—
-1.0e+50
—
—
—
-1.0e+50
1.4e+00
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.92%
controls:0.22%
—
0
8
1473
14436
—
—
—
0
6
1463
14391
13
31
1400
13885
Migraine with aura [classical migraine]
G43.1 [45562086]
6.2e-01
1.4e+00
-1.0e+50
—
—
9.0e-01
2.6e-01
cases:0.75%
controls:0.40%
cases:0.88%
controls:0.21%
cases:0.00%
controls:0.06%
—
—
—
—
cases:0.55%
controls:0.22%
cases:0.92%
controls:0.71%
11
58
1455
14322
13
31
1460
14413
0
8
1473
14436
—
—
8
32
1455
14365
13
99
1400
13817
Laceration/cut
S18 [2002000983]
4.8e-01
8.9e-01
—
—
—
5.1e-01
5.2e-01
cases:2.11%
controls:1.31%
cases:1.36%
controls:0.56%
—
—
—
—
—
—
cases:0.89%
controls:0.53%
cases:3.54%
controls:2.13%
31
189
1435
14191
20
81
1453
14363
—
—
—
13
77
1450
14320
50
296
1363
13620
Eating disorder, unspecified
F50.9 [45547713]
1.3e+00
—
—
—
—
—
1.4e+00
cases:0.34%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.22%
5
14
1461
14366
—
—
—
—
—
12
30
1401
13886
trazodone; oral
N06AX05 [21604734]
1.6e+00
—
—
—
—
—
1.4e+00
cases:0.41%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.18%
6
12
1460
14368
—
—
—
—
—
10
25
1403
13891
Essential hypertension, Unspecified
4019X [2000403546]
1.4e+00
—
—
—
—
—
1.2e+00
cases:0.75%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.12%
11
28
1455
14352
—
—
—
—
—
6
17
1407
13899
pramipexole; oral
N04BC05 [21604477]
1.4e+00
1.6e+00
—
—
—
—
5.2e-01
cases:0.75%
controls:0.19%
cases:0.54%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.34%
11
28
1455
14352
8
16
1465
14428
—
—
—
—
8
47
1405
13869
Differential panel, method unspecified - Blood
69738-3 [42870588]
2.9e-02
4.0e-01
1.8e-01
2.3e+00
1.1e+00
7.4e-01
6.1e-01
cases:2.05%
controls:1.99%
cases:2.10%
controls:1.42%
cases:0.41%
controls:0.34%
cases:0.34%
controls:0.03%
cases:0.82%
controls:0.27%
cases:3.08%
controls:1.49%
cases:5.45%
controls:3.04%
30
286
1436
14094
31
205
1442
14239
6
49
1467
14395
5
5
1468
14439
12
39
1460
14403
45
214
1418
14183
77
423
1336
13493
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
7.0e-02
8.1e-01
—
—
1.5e+00
4.3e-01
5.4e-01
cases:3.96%
controls:3.70%
cases:2.44%
controls:1.10%
—
—
—
—
cases:0.48%
controls:0.10%
cases:1.71%
controls:1.12%
cases:9.48%
controls:5.76%
58
532
1408
13848
36
159
1437
14285
—
—
7
15
1465
14427
25
161
1438
14236
134
801
1279
13115
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
1.5e-01
7.9e-01
—
—
—
9.9e-01
1.3e+00
cases:0.61%
controls:0.53%
cases:0.61%
controls:0.28%
—
—
—
—
—
—
cases:0.62%
controls:0.23%
cases:1.20%
controls:0.32%
9
76
1457
14304
9
40
1464
14404
—
—
—
9
33
1454
14364
17
44
1396
13872
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.22%
—
—
—
—
—
—
12
31
1401
13885
Malaise and fatigue
R53 [45553741]
6.5e-01
1.1e+00
—
—
-1.0e+50
1.3e+00
5.5e-01
cases:1.09%
controls:0.57%
cases:0.81%
controls:0.28%
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.03%
controls:0.27%
cases:2.62%
controls:1.52%
16
82
1450
14298
12
41
1461
14403
—
—
0
8
1472
14434
15
39
1448
14358
37
212
1376
13704
esomeprazole; oral, parenteral
A02BC05 [21600100]
2.1e-01
5.8e-01
8.7e-01
—
1.3e+00
4.6e-01
1.0e-01
cases:3.00%
controls:2.45%
cases:2.10%
controls:1.18%
cases:0.61%
controls:0.26%
—
—
cases:1.02%
controls:0.27%
cases:2.12%
controls:1.35%
cases:4.32%
controls:3.92%
44
353
1422
14027
31
171
1442
14273
9
37
1464
14407
—
15
39
1457
14403
31
195
1432
14202
61
545
1352
13371
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
7.4e-01
7.0e-01
—
—
—
1.3e+00
3.3e-01
cases:0.48%
controls:0.23%
cases:0.54%
controls:0.27%
—
—
—
—
—
—
cases:0.75%
controls:0.20%
cases:0.99%
controls:0.71%
7
33
1459
14347
8
39
1465
14405
—
—
—
11
29
1452
14368
14
99
1399
13817
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
4.3e-02
8.6e-01
—
—
—
1.0e+00
1.3e+00
cases:0.68%
controls:0.65%
cases:0.48%
controls:0.20%
—
—
—
—
—
—
cases:0.55%
controls:0.19%
cases:1.98%
controls:0.55%
10
94
1456
14286
7
29
1466
14415
—
—
—
8
28
1455
14369
28
76
1385
13840
Standard cardiac ultrasound examination
FM1AE [2001303278]
7.5e-01
7.9e-01
—
—
—
1.3e+00
6.6e-01
cases:1.30%
controls:0.62%
cases:0.61%
controls:0.28%
—
—
—
—
—
—
cases:0.89%
controls:0.24%
cases:1.56%
controls:0.81%
19
89
1447
14291
9
40
1464
14404
—
—
—
13
35
1450
14362
22
113
1391
13803
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
5.9e-01
1.3e+00
—
—
—
8.1e-01
4.2e-01
cases:1.98%
controls:1.11%
cases:1.22%
controls:0.34%
—
—
—
—
—
—
cases:0.89%
controls:0.40%
cases:2.12%
controls:1.40%
29
159
1437
14221
18
49
1455
14395
—
—
—
13
57
1450
14340
30
195
1383
13721
Medical examin/health eval partial
-31 [2002000102]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.29%
—
—
—
—
—
—
15
41
1398
13875
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
6.8e-01
-1.0e+50
—
—
—
—
1.3e+00
cases:0.48%
controls:0.24%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.34%
7
35
1459
14345
0
13
1473
14431
—
—
—
—
17
47
1396
13869
Functional capacity evaluation
443351003 [40481051]
5.4e-01
—
—
—
—
1.3e+00
1.3e+00
cases:0.82%
controls:0.48%
—
—
—
—
—
—
—
—
cases:0.62%
controls:0.17%
cases:1.56%
controls:0.45%
12
69
1454
14311
—
—
—
—
9
24
1454
14373
22
62
1391
13854
dipyridamole; oral, parenteral
B01AC07 [21600992]
—
1.2e+00
—
—
—
1.4e+00
1.2e+00
—
—
cases:0.34%
controls:0.10%
—
—
—
—
—
—
cases:0.41%
controls:0.10%
cases:0.92%
controls:0.27%
—
5
15
1468
14429
—
—
—
6
15
1457
14382
13
37
1400
13879
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
6.5e-01
6.9e-01
1.2e+00
—
8.2e-01
6.7e-01
5.9e-01
cases:4.23%
controls:2.25%
cases:1.77%
controls:0.89%
cases:0.48%
controls:0.14%
—
—
cases:0.41%
controls:0.18%
cases:1.98%
controls:1.03%
cases:6.30%
controls:3.59%
62
323
1404
14057
26
129
1447
14315
7
20
1466
14424
—
6
26
1466
14416
29
148
1434
14249
89
499
1324
13417
Scheduled procedure
ZXD10 [2001311387]
5.2e-01
6.1e-01
—
—
1.6e+00
7.3e-01
7.2e-01
cases:5.66%
controls:3.44%
cases:1.77%
controls:0.96%
—
—
—
—
cases:0.41%
controls:0.08%
cases:1.57%
controls:0.76%
cases:6.02%
controls:3.01%
83
495
1383
13885
26
139
1447
14305
—
—
6
12
1466
14430
23
110
1440
14287
85
419
1328
13497
Mild depressive episode without somatic syndrome
F32.00 [2000501978]
—
—
—
—
—
—
1.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.35%
—
—
—
—
—
—
17
49
1396
13867
Dedicated profession-specific psychiatric intervention, individual
IEY05 [2001304224]
1.0e+00
-1.0e+50
—
—
—
1.1e+00
1.2e+00
cases:0.34%
controls:0.13%
cases:0.00%
controls:0.10%
—
—
—
—
—
—
cases:0.41%
controls:0.13%
cases:1.20%
controls:0.36%
5
18
1461
14362
0
15
1473
14429
—
—
—
6
19
1457
14378
17
50
1396
13866
prednisolone; oral, parenteral
H02AB06 [21602734]
2.5e-01
7.3e-01
—
—
1.2e+00
2.9e-01
4.7e-01
cases:4.23%
controls:3.32%
cases:2.78%
controls:1.36%
—
—
—
—
cases:0.54%
controls:0.16%
cases:1.85%
controls:1.39%
cases:7.22%
controls:4.62%
62
477
1404
13903
41
196
1432
14248
—
—
8
23
1464
14419
27
200
1436
14197
102
643
1311
13273
prednisolone
A07EA01 [21600653]
2.4e-01
7.3e-01
—
—
1.2e+00
2.8e-01
4.7e-01
cases:4.23%
controls:3.34%
cases:2.78%
controls:1.36%
—
—
—
—
cases:0.54%
controls:0.16%
cases:1.85%
controls:1.40%
cases:7.22%
controls:4.64%
62
481
1404
13899
41
196
1432
14248
—
—
8
23
1464
14419
27
201
1436
14196
102
646
1311
13270
FEV1 --post bronchodilation
20155-8 [3023550]
8.4e-01
—
—
—
—
1.1e+00
1.2e+00
cases:1.09%
controls:0.47%
—
—
—
—
—
—
—
—
cases:0.48%
controls:0.16%
cases:1.56%
controls:0.48%
16
68
1450
14312
—
—
—
—
7
23
1456
14374
22
67
1391
13849
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
8.4e-01
—
—
—
—
1.1e+00
1.2e+00
cases:1.09%
controls:0.47%
—
—
—
—
—
—
—
—
cases:0.48%
controls:0.16%
cases:1.56%
controls:0.48%
16
68
1450
14312
—
—
—
—
7
23
1456
14374
22
67
1391
13849
FVC percent change Respiratory system
69982-7 [42868471]
8.4e-01
—
—
—
—
1.1e+00
1.2e+00
cases:1.09%
controls:0.47%
—
—
—
—
—
—
—
—
cases:0.48%
controls:0.16%
cases:1.56%
controls:0.48%
16
68
1450
14312
—
—
—
—
7
23
1456
14374
22
67
1391
13849

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
449
172
34.48
307.65
5.4
6.4
399.63
371.25
umol/l
1.45
416
148
753
3873
2.63
83.13
3.5
2.1
182.75
199.70
u/l
0.33
736
3707
1007
6752
2.12
51.87
8.0
7.7
1.21
1.21
mmol/l
1.90
896
5921
914
5992
2.07
49.02
7.2
7.5
1.21
1.21
mmol/l
2.65
873
5594
146
414
3.75
44.46
2.5
2.4
627.03
330.25
ug/l
0.43
140
390
1125
8382
1.92
37.31
6.4
5.3
6.42
6.47
mmol/l
0.30
1064
7812
104
303
3.58
30.31
2.7
3.7
34.13
33.36
umol/l
0.15
94
282
287
1524
2.05
24.84
4.7
6.1
7.37
7.38
ph
0.25
174
919
578
3864
1.73
24.14
4.3
4.2
7.40
7.40
ph
0.51
435
2712
255
1349
2.04
22.16
7.7
9.5
7.42
7.41
ph
0.15
154
733
272
1475
1.99
22.04
4.6
6.1
1.22
1.58
mmol/l
0.82
231
1249
276
1517
1.97
21.49
4.6
6.0
5.80
5.81
kpa
0.08
259
1477
252
1351
2.01
21.04
7.6
9.5
5.10
5.11
kpa
0.10
245
1296
249
1330
2.01
21.01
7.7
9.6
0.99
0.77
mmol/l
0.35
203
1091
252
1352
2.00
21.00
7.6
9.4
12.96
12.67
kpa
0.33
244
1300
215
1109
2.07
19.92
8.3
10.3
123.26
122.72
g/l
0.15
209
1087
949
7444
1.58
19.81
7.4
7.2
0.66
0.68
%
0.53
905
7034
724
5338
1.60
19.66
4.0
3.5
28.49
31.21
u/l
1.69
690
5087
365
2251
1.78
19.65
3.8
4.6
0.81
0.82
mmol/l
0.73
347
2147
949
7468
1.57
19.35
7.4
7.2
8.92
8.54
%
3.99
906
7070
947
7451
1.57
19.31
7.3
7.1
2.56
2.88
%
4.33
904
7047
509
3454
1.66
19.29
5.2
4.1
—
—
—
0
0
754
5642
1.58
19.05
12.8
11.2
1.17
1.18
inr
0.14
637
4684
785
5944
1.57
18.74
5.3
5.5
36.00
36.73
g/l
3.16
746
5610
1007
8068
1.57
18.71
7.1
7.0
0.04
0.04
e9/l
1.46
878
6996
617
4419
1.60
18.69
2.8
2.6
60.59
59.47
u/l
0.05
576
4144
1005
8059
1.56
18.51
7.1
7.0
0.58
0.56
e9/l
1.25
877
6988
955
7596
1.55
18.06
7.0
6.9
53.89
55.78
%
5.23
923
7311
1029
8329
1.55
17.92
7.8
7.3
0.17
0.19
e9/l
2.01
911
7346
968
7732
1.55
17.88
7.4
7.1
31.22
29.63
%
4.27
931
7391
1023
8280
1.55
17.73
7.3
7.0
2.00
2.01
e9/l
0.15
908
7374
645
4777
1.55
16.38
4.1
3.2
24.74
72.26
ng/l
1.36
395
2794
216
1200
1.91
16.08
8.2
10.1
95.82
95.75
%
0.06
209
1164
141
681
2.16
15.44
8.5
6.9
24.61
24.36
mmol/l
0.29
135
648
908
7292
1.50
15.41
6.3
6.5
8.96
11.89
umol/l
9.36
856
6945
509
3617
1.57
15.34
1.8
1.6
19.92
19.98
nmol/l
0.03
460
3169
297
1885
1.69
14.03
1.7
1.7
1106.15
1139.47
nmol/l
0.25
237
1470
1060
8884
1.47
13.86
11.6
9.8
3.86
3.98
e9/l
0.85
923
7743
545
4005
1.52
13.84
3.5
2.7
—
—
—
0
0
225
1330
1.79
13.67
4.3
5.6
4.80
4.79
kpa
0.04
211
1295
152
804
1.97
13.03
4.6
5.3
128.85
130.68
g/l
0.43
144
783
193
1105
1.84
13.00
4.4
5.9
5.16
5.09
kpa
0.69
186
1071
134
681
2.05
12.84
9.8
12.4
16.43
16.11
%
0.66
129
654
33
80
4.18
12.52
1.8
3.8
163.81
138.07
umol/l
0.15
16
46
218
1310
1.76
12.48
7.3
10.8
—
—
—
0
0
1250
10924
1.48
12.44
8.2
7.7
78.96
79.75
u/l
0.28
1181
10415
729
5780
1.44
12.23
2.1
2.0
96.48
97.10
pmol/l
0.14
396
3197
360
2473
1.57
12.22
4.2
3.5
200.85
519.10
ng/l
2.39
239
1630
58
207
2.86
12.18
1.5
1.7
67.63
68.72
mmol/l
0.05
46
174
187
1085
1.81
12.05
4.5
5.9
7.41
7.41
ph
1.34
145
901
111
540
2.13
11.95
4.8
4.0
24.96
25.18
mmol/l
0.26
105
520
101
474
2.20
11.90
8.2
5.6
0.91
0.88
%
0.35
94
445
311
2079
1.60
11.83
2.0
2.7
28.86
29.52
s
0.90
301
2025
1601
14837
1.73
11.70
21.9
14.6
138.78
139.63
mmol/l
23.30
1567
14542
605
4666
1.45
11.63
3.0
3.3
2.34
2.35
mmol/l
2.00
559
4332
80
350
2.35
11.14
1.5
2.0
—
—
—
0
0
83
373
2.28
10.87
1.5
1.9
4.87
15.77
e6/l
1.95
60
275
176
1035
1.78
10.83
4.3
6.5
23.91
23.90
mmol/l
0.02
170
1027
106
532
2.05
10.53
7.7
5.3
1.80
1.58
%
1.10
99
502
83
379
2.25
10.48
1.5
1.9
834.83
1359.25
e6/l
0.23
65
292
81
368
2.26
10.36
8.5
6.2
1.53
1.25
mmol/l
1.36
68
320
88
416
2.17
10.22
1.3
1.8
501.01
488.98
mg/l
0.05
82
401
1595
14867
1.65
10.13
21.6
14.7
3.97
3.94
mmol/l
3.30
1560
14540
590
4627
1.41
10.01
6.8
6.2
—
—
—
0
0
527
6649
0.71
9.88
2.8
2.7
—
—
—
0
0
222
1441
1.62
9.44
2.8
2.5
34.00
73.09
u/l
0.60
198
1205
89
437
2.09
9.40
2.6
1.9
1.03
1.92
ug/l
0.65
76
386
58
241
2.45
9.10
4.4
3.9
2.34
2.33
mmol/l
0.01
40
149
1112
9776
1.36
8.86
5.3
4.2
428.08
1737.56
e6/l
1.32
24
131
57
239
2.43
8.78
10.3
7.7
11.46
11.41
mmol/l
0.03
52
219
57
240
2.42
8.70
10.3
7.6
103.65
105.31
mmol/l
1.41
52
220
207
1348
1.61
8.67
2.3
2.8
0.22
0.22
g/l
0.30
199
1272
100
530
1.94
8.57
2.5
2.8
—
—
—
0
0
364
2682
1.45
8.53
2.8
2.9
544.94
541.08
mosm/kgh2o
0.11
325
2364
460
3547
1.40
8.34
1.8
2.0
1.25
1.06
mg/l
0.29
344
2677
275
1926
1.51
8.32
5.8
7.5
1.11
1.09
mmol/l
0.32
256
1809
810
6842
1.34
8.14
2.8
2.6
73.76
73.73
nmol/l
0.01
742
6401
126
2055
0.58
7.84
1.2
1.3
—
—
—
0
0
497
3935
1.36
7.55
2.3
2.4
2.63
2.66
mg/l
0.13
422
3438
220
1500
1.53
7.53
3.3
3.5
1.81
1.71
%
0.84
197
1370
33
115
2.90
7.34
2.8
2.0
—
—
—
0
0
173
1123
1.60
7.34
3.9
3.9
7.37
7.35
ph
0.93
142
837
461
3637
1.36
7.10
4.2
3.5
1.02
1.86
kg/l
0.80
329
2386
127
770
1.70
7.04
8.0
12.4
1.31
1.33
%
0.08
127
764
234
1647
1.48
6.87
1.9
2.2
379.58
371.68
nmol/l
0.23
219
1546
71
364
1.99
6.75
3.0
3.0
6.47
3.32
index
0.67
38
200
43
181
2.41
6.64
1.8
2.2
—
—
—
0
0
1359
14484
0.75
6.29
4.6
4.4
1.46
1.45
mmol/l
0.66
1279
13756
1380
14659
0.75
6.06
5.2
4.9
2.77
2.79
mmol/l
0.24
1303
13936
499
4068
1.31
6.00
3.6
3.1
—
1.00
—
0
8
263
1942
1.42
5.97
3.7
3.2
3.78
4.80
e9/l
2.24
230
1743
812
7058
1.27
5.92
11.1
10.6
0.00
0.00
e9/l
0.67
637
5720
128
816
1.61
5.88
2.9
3.0
119.47
165.85
ng/l
1.13
118
732
128
820
1.60
5.77
5.0
6.3
—
—
—
0
0
136
886
1.58
5.71
2.8
2.8
—
—
—
0
0
88
516
1.74
5.55
1.7
2.1
1.25
1.39
g/l
0.69
79
466
398
3182
1.32
5.44
2.9
3.3
713.07
1135.17
ng/l
3.14
329
2665
151
1021
1.52
5.38
3.9
5.0
84.60
80.16
ng/l
0.20
127
930
547
4573
1.28
5.33
3.3
3.4
59.77
65.48
e6/l
0.07
437
3424
49
241
2.06
5.28
2.6
2.5
16.56
16.65
%
0.09
49
236
1280
13671
0.78
5.26
3.9
3.8
1.33
1.26
mmol/l
2.16
1201
12920
1375
14545
0.77
5.16
4.7
4.5
4.70
4.68
mmol/l
0.48
1302
13884
159
1097
1.49
5.16
2.8
3.4
68.46
70.63
e9/l
0.31
117
775
242
1814
1.39
5.02
1.8
1.7
—
—
—
0
0
144
984
1.50
4.90
2.1
2.1
—
—
—
0
0
303
2371
1.33
4.76
2.5
2.6
13.46
14.17
umol/l
0.97
285
2234
117
1731
0.65
4.75
1.5
1.6
3.60
3.45
mmol/l
0.71
75
1144
445
3673
1.28
4.72
4.6
4.4
95.35
91.92
%
2.50
437
3592
57
310
1.87
4.65
2.2
2.4
130.68
132.12
g/l
0.25
50
258
259
1987
1.35
4.64
2.5
2.7
23.33
23.81
%
0.22
240
1873
640
5523
1.25
4.64
4.0
4.0
60.17
81.30
e6/l
0.52
453
3676
40
192
2.11
4.63
1.3
2.5
—
—
—
0
0
53
283
1.90
4.58
4.2
3.8
—
—
—
0
0
123
828
1.52
4.51
1.7
1.7
0.26
0.30
mg/l
0.59
53
381
282
2201
1.33
4.50
2.5
2.6
2.36
2.40
g/l
0.52
264
2056
110
730
1.54
4.32
5.1
6.3
24.09
24.43
mmol/l
0.72
104
705
50
268
1.89
4.29
3.2
3.9
90.46
90.48
%
0.01
50
258
163
1175
1.43
4.24
2.3
2.4
6642.87
6618.29
u/l
0.00
67
488
167
2262
0.71
4.23
1.7
1.8
3.63
3.48
ratio
0.70
123
1671
63
366
1.75
4.18
4.1
4.0
1.37
1.37
mmol/l
0.00
63
357
327
2642
1.29
4.05
1.7
1.7
453.16
40915457.58
pmol/l
3.28
280
2295
256
2002
1.33
4.03
2.1
2.0
—
—
—
0
0
147
2015
0.71
4.00
2.8
2.9
0.70
0.76
ug/l
0.36
96
1129
1189
11058
1.22
3.90
4.3
3.3
54.90
40.55
u/l
5.84
1152
10626
288
2304
1.30
3.84
2.8
3.1
5.73
2.66
e6/l
2.03
152
1105
167
1238
1.38
3.72
2.2
2.0
—
—
—
0
0
82
530
1.57
3.66
1.1
1.1
2.06
5.58
eliau/ml
1.06
13
79
157
1156
1.39
3.65
2.3
2.1
—
—
—
0
0
167
1244
1.38
3.62
2.2
2.0
—
—
—
0
0
11
25
4.42
3.62
1.6
1.2
—
—
—
0
0
167
1248
1.37
3.55
2.2
2.0
—
—
—
0
0
35
178
1.99
3.54
1.4
1.2
—
—
—
0
0
166
1240
1.37
3.54
7.9
9.7
7.84
8.19
mmol/l
0.28
158
1198
371
3092
1.25
3.54
2.7
2.7
8.89
6.45
e6/l
1.30
339
2807
99
673
1.50
3.53
1.8
2.0
7.38
7.52
iu/ml
0.02
21
160
133
961
1.41
3.46
4.1
3.7
1.21
1.23
mmol/l
2.42
121
816
534
4641
1.21
3.41
3.7
3.7
7.71
8.11
mmol/l
1.00
459
4082
164
1231
1.37
3.40
2.2
2.0
—
—
—
0
0
145
1070
1.39
3.34
2.4
2.5
0.46
0.38
e6/l
0.13
140
1016
59
362
1.65
3.28
4.0
6.9
64.16
64.51
%
0.04
54
352
72
469
1.56
3.15
1.4
1.3
27.92
8.70
u/ml
0.60
11
63
72
469
1.56
3.15
1.4
1.3
9.22
2.50
u/ml
—
5
35
459
3959
1.21
3.14
3.2
3.3
0.36
0.32
e6/l
0.31
358
2829
291
2394
1.26
3.10
1.4
1.4
641.51
471.44
titre
0.50
53
472
147
1103
1.36
3.08
2.3
2.4
14.73
21.42
au/ml
—
10
144
17
68
2.51
3.04
1.9
2.8
7.57
8.29
mmol/l
0.58
17
68
1573
15200
1.28
3.02
19.8
13.4
22.39
21.93
mg/l
0.23
1354
12266
53
840
0.62
3.01
1.1
1.1
0.86
0.89
g/l
0.34
53
840
24
113
2.14
3.01
1.3
1.1
—
—
—
0
0
1632
15853
1.32
2.96
13.5
10.7
25.46
26.59
u/l
2.00
1590
15496
1286
12185
1.20
2.92
5.1
4.4
14.04
14.53
pmol/l
10.58
1207
11401
136
1020
1.36
2.87
1.3
1.3
71.24
47.83
au/ml
—
5
65
29
150
1.95
2.85
1.1
1.2
29.27
40.38
mg/l
1.13
23
121
25
123
2.05
2.82
1.3
1.2
0.56
0.62
ratio
0.47
19
73
20
90
2.24
2.80
1.5
2.7
2.14
1.82
u/field
0.17
14
55
119
878
1.38
2.79
1.9
2.2
7.08
7.67
ug/l
0.07
99
790
9
23
3.93
2.77
1.2
1.8
—
—
—
0
0
53
822
0.63
2.76
1.0
1.1
1.53
1.52
g/l
0.06
53
822
293
2450
1.23
2.69
2.4
2.7
2.42
2.43
mmol/l
0.41
265
2197
76
523
1.47
2.62
1.7
1.8
0.21
0.23
g/l
1.51
67
496
10
30
3.35
2.60
1.0
1.2
—
—
—
0
0
503
4443
1.18
2.60
1.5
1.4
2.07
1.58
u/ml
0.36
118
1208
544
4837
1.18
2.60
2.6
2.4
—
—
—
0
0
7
15
4.68
2.59
1.0
1.3
—
—
—
0
0
225
1839
1.26
2.54
1.5
1.5
—
—
—
0
0
51
324
1.59
2.53
3.1
3.7
32.63
38.72
mg/l
0.37
44
274
51
324
1.59
2.53
3.2
3.7
47.63
65.08
mg/l
0.40
43
273
114
851
1.36
2.51
1.9
1.9
—
—
—
0
0
1462
14077
1.21
2.50
6.2
5.2
1.86
1.82
mu/l
0.57
1391
13326
291
2452
1.22
2.49
2.7
2.9
1.23
1.17
e6/l
0.08
157
1247
883
8173
1.16
2.49
4.2
3.6
10.71
5.78
estimate
0.18
188
1654
34
195
1.76
2.47
1.2
1.5
39.89
129.36
mu/l
0.96
28
175
166
1318
1.29
2.39
2.0
2.0
0.00
0.02
estimate
0.78
43
307
161
1274
1.29
2.38
5.5
5.0
0.87
0.93
%
0.11
60
374
8
22
3.65
2.36
1.8
1.3
—
—
—
0
0
192
1556
1.26
2.35
1.2
1.2
—
—
—
0
0
727
6657
1.15
2.33
3.5
3.2
6.46
6.20
ph
7.48
418
3800
34
201
1.70
2.25
3.3
3.7
1.26
1.53
%
0.19
29
186
82
593
1.40
2.22
2.3
1.7
—
—
—
0
0
19
93
2.05
2.21
1.2
1.4
225871.54
24133.43
e6/l
0.79
13
51
76
543
1.42
2.20
1.7
1.7
1.14
1.19
g/l
0.57
67
514
287
2450
1.20
2.16
1.7
1.7
—
—
—
0
0
78
1065
0.72
2.15
1.4
1.6
—
—
—
0
0
34
204
1.68
2.15
1.6
1.6
—
—
—
0
0
437
3876
1.17
2.11
1.5
1.5
2.31
2.18
g/l
0.49
254
2474
83
608
1.38
2.10
2.4
2.3
—
—
—
0
0
91
677
1.36
2.09
1.3
1.2
0.20
1.31
u/ml
—
6
49
44
285
1.56
2.07
3.1
3.6
1.83
2.53
ratio
0.43
22
161
29
169
1.73
2.04
2.1
3.5
—
—
—
0
0
6
15
4.01
2.04
1.0
1.2
—
—
—
0
0
879
8208
1.14
2.03
4.2
3.6
0.00
0.20
estimate
0.54
177
1577
29
170
1.72
2.00
7.1
6.1
10.82
10.77
mg/l
0.02
24
157
26
148
1.77
1.99
1.4
2.2
—
—
—
0
0
150
1207
1.26
1.98
3.5
2.2
6.32
6.14
ph
1.48
102
777
152
1226
1.26
1.97
5.3
4.8
0.65
0.65
%
0.01
59
356
212
1774
1.22
1.96
2.6
3.5
5.58
7.26
umol/l
1.12
177
1533
42
273
1.55
1.96
4.1
4.0
—
—
—
0
0
152
1864
0.80
1.93
1.3
1.3
—
—
—
0
0
13
58
2.25
1.91
1.9
1.3
—
—
—
0
0
92
698
1.34
1.89
2.0
2.1
0.07
1.02
estimate
0.46
29
249
5
12
4.18
1.82
1.2
1.2
—
—
—
0
0
5
12
4.18
1.82
1.6
1.1
45.98
39.86
nmol/l
—
5
12
159
1309
1.24
1.74
3.1
3.0
10.92
10.36
g/l
0.93
151
1228
525
5742
0.88
1.73
2.1
2.0
—
—
—
0
0
22
125
1.77
1.72
4.1
3.5
15.00
13.86
index
0.10
15
94
17
89
1.92
1.70
1.1
1.4
—
—
—
0
0
1014
9624
1.12
1.67
3.7
3.4
—
29431.21
—
0
14
170
1417
1.22
1.67
1.3
1.3
129.41
138.00
u/ml
0.10
60
548
42
286
1.48
1.63
1.9
1.6
619.57
353.02
mu/l
1.20
35
241
83
637
1.32
1.61
3.2
3.0
1.02
1.02
ratio
0.75
71
590
860
8097
1.12
1.61
4.2
3.6
0.00
0.00
estimate
0.50
186
1645
150
1241
1.23
1.59
5.7
5.4
0.16
0.41
%
0.43
43
297
148
1223
1.23
1.59
5.8
5.1
0.23
0.11
%
0.48
48
319
1657
16816
0.81
1.56
30.4
20.3
6.73
6.76
e9/l
0.18
1629
16486
295
3333
0.86
1.55
3.9
4.7
1.67
2.13
ug/l
1.57
268
3035
64
476
1.36
1.54
1.1
1.4
80.00
90.18
titre
—
5
55
751
7032
1.12
1.53
3.1
2.8
—
—
estimate
—
0
0
1658
16819
0.81
1.49
30.5
20.4
134.29
136.35
g/l
7.85
1647
16689
89
1122
0.78
1.47
1.4
1.4
—
—
—
0
0
22
354
0.62
1.46
1.2
1.3
—
—
—
0
0
220
1904
1.18
1.46
1.3
1.2
—
—
—
0
0
9
38
2.38
1.45
5.4
2.1
1.09
1.23
umol/l
—
9
28
131
1080
1.23
1.45
2.9
3.7
4.51
4.67
pmol/l
1.23
116
977
115
935
1.25
1.45
1.3
1.2
—
—
—
0
0
1658
16812
0.82
1.42
30.3
20.3
4.45
4.56
e12/l
15.79
1630
16494
1658
16811
0.82
1.41
30.2
20.2
30.35
30.10
pg
6.77
1648
16682
1658
16811
0.82
1.41
30.8
20.8
39.92
41.18
%
2.89
1648
16672
1623
15939
1.19
1.39
22.1
15.8
70.26
72.96
umol/l
2.08
1606
15773
13
67
1.95
1.38
4.5
2.6
2.96
2.67
mmol/l
0.27
13
59
1658
16808
0.82
1.38
30.2
20.2
90.48
90.07
fl
3.10
1648
16681
6
23
2.61
1.37
1.0
1.0
64.00
72.35
titre
—
6
23
5
17
2.95
1.36
2.2
3.3
0.30
0.20
%
—
5
17
78
611
1.29
1.35
1.5
1.3
—
—
—
0
0
1658
16803
0.83
1.33
30.4
20.3
249.69
257.28
e9/l
5.46
1631
16518
12
61
1.97
1.33
1.4
1.7
—
—
—
0
0
40
283
1.42
1.32
1.1
1.3
2.38
5.34
u/ml
1.87
16
134
9
43
2.10
1.30
1.0
1.1
—
—
—
0
0
9
43
2.10
1.30
1.0
1.1
—
—
—
0
0
420
3838
1.12
1.29
5.3
4.7
—
—
—
0
0
8
34
2.36
1.29
2.3
1.5
41.25
41.32
g/l
—
8
34
13
69
1.89
1.28
3.4
1.7
107.88
105.30
ng/l
0.04
13
69
35
243
1.45
1.28
1.2
1.6
50.03
23.67
ng/l
0.49
35
243
8
35
2.29
1.27
1.4
1.4
6.62
11.45
mmol/l
—
8
35
85
681
1.26
1.25
2.0
3.3
20.67
20.89
s
0.23
79
619
21
131
1.61
1.23
1.1
1.2
—
—
—
0
0
9
45
2.00
1.23
2.8
2.2
—
—
—
0
0
20
124
1.62
1.21
1.1
1.0
—
—
—
0
0
39
281
1.40
1.19
6.0
3.6
19.33
26.24
mg/l
1.20
28
200
12
64
1.88
1.18
1.1
1.2
—
—
—
0
0
16
94
1.71
1.17
1.6
1.2
—
105.80
—
0
5
28
190
1.48
1.16
1.0
1.2
2.00
4.08
u/ml
—
10
88
67
527
1.28
1.15
1.3
1.3
—
—
—
0
0
18
110
1.64
1.15
1.2
1.3
—
—
—
0
0
8
39
2.06
1.15
7.4
7.9
4.42
5.09
kpa
—
8
39
5
20
2.50
1.15
1.6
1.9
—
—
—
0
0
5
20
2.50
1.15
1.2
3.1
—
—
—
0
0
30
208
1.45
1.13
2.0
2.4
—
—
—
0
0
7
30
2.34
1.12
2.7
3.3
11.57
5.86
ug/l
—
7
30
502
4671
1.10
1.10
3.3
2.8
0.00
0.03
0.49
14
71
52
398
1.32
1.10
1.4
1.3
—
6.90
—
0
6
16
96
1.67
1.10
2.4
2.5
—
—
—
0
0
41
303
1.36
1.09
1.0
1.1
—
—
—
0
0
42
313
1.35
1.07
1.1
1.1
—
—
—
0
0
16
254
0.63
1.06
1.5
1.6
—
—
—
0
0
65
516
1.27
1.06
1.4
1.3
—
—
—
0
0
69
553
1.26
1.04
2.6
5.1
358.94
327.79
mg/l
0.11
34
286
5
22
2.28
1.03
2.2
2.0
—
—
—
0
0
461
4295
1.10
0.99
4.3
3.6
0.00
0.01
estimate
1.94
171
1555
42
318
1.33
0.98
1.1
1.1
2.59
2.35
eliau/ml
0.11
16
142
10
54
1.86
0.96
1.0
1.5
67.00
82.44
nmol/24h
—
10
54
12
69
1.74
0.96
1.5
3.9
88.80
49.95
umol/l
—
5
13
41
311
1.33
0.95
1.1
1.1
52.00
1665.93
iu/ml
—
8
81
408
3786
1.10
0.95
1.8
1.8
—
—
—
0
0
13
77
1.69
0.95
1.1
1.5
147.85
143.22
nmol/l
0.10
13
77
17
109
1.56
0.93
1.1
1.0
—
—
—
0
0
37
278
1.34
0.92
2.9
3.5
9.39
7.71
pmol/l
0.27
37
278
62
500
1.25
0.92
1.9
2.2
2.54
3.96
iu/l
2.80
20
219
114
978
1.18
0.91
1.7
1.7
307.83
294.68
mu/l
0.22
102
887
15
94
1.60
0.90
4.8
3.9
0.33
0.84
index
2.73
15
94
11
63
1.75
0.90
3.9
3.2
15.12
16.51
%
1.07
11
63
651
6183
1.08
0.89
4.2
3.4
0.02
0.05
estimate
0.46
153
1381
56
694
0.80
0.88
1.4
1.5
1.20
1.27
mm
0.54
42
506
496
4660
1.09
0.88
3.6
2.9
0.02
0.07
estimate
0.50
145
1345
408
3801
1.09
0.88
3.9
3.6
73.50
57.38
mg/l
0.62
287
2531
54
432
1.26
0.86
1.3
1.4
291.25
302.22
ug/g
0.16
32
245
11
64
1.72
0.86
1.2
1.2
—
—
—
0
0
182
1625
1.13
0.86
1.5
1.5
—
—
—
0
0
6
112
0.53
0.83
1.3
1.4
185.50
162.62
pmol/l
—
6
112
26
188
1.39
0.83
1.2
1.3
0.57
9.96
nmol/l
0.50
26
181
21
146
1.44
0.82
1.7
2.1
1.18
0.91
%
0.82
13
86
413
3863
1.09
0.82
4.6
4.3
13.22
14.01
mg/mmol
0.05
281
2521
58
708
0.81
0.81
1.3
1.5
—
—
—
0
0
1308
13362
0.92
0.81
6.1
5.3
38.30
38.05
mmol/mol
0.38
1232
12750
143
1613
0.88
0.79
1.5
1.6
1083.12
999.40
mu/l
0.40
122
1366
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
0
26
0.00
0.78
0.0
1.2
—
26.71
—
0
7
0
26
0.00
0.78
0.0
1.2
—
17.88
—
0
8
1368
13410
1.08
0.77
24.6
16.4
13.28
13.39
%
3.22
1354
13246
20
140
1.43
0.77
1.9
2.8
1.34
1.34
g/24h
—
10
92
121
1061
1.15
0.76
1.2
1.2
—
—
—
0
0
23
166
1.39
0.75
1.2
1.4
2.82
3.95
u/ml
0.23
13
98
12
75
1.60
0.75
2.3
3.3
—
—
—
0
0
23
167
1.38
0.73
1.2
1.3
—
—
nmol/l
—
0
0
23
167
1.38
0.73
1.0
1.1
0.06
4.85
u/ml
—
7
56
5
25
2.00
0.72
1.4
2.2
1.90
2.66
%
—
5
25
9
56
1.61
0.72
4.8
2.3
27.11
29.36
%
—
9
56
10
60
1.67
0.72
1.2
1.3
—
—
—
0
0
17
240
0.71
0.70
2.0
1.4
—
—
—
0
0
115
1013
1.14
0.69
1.6
1.9
1.51
1.28
g/l
0.68
106
953
39
310
1.26
0.69
1.4
1.3
14.79
19.96
u/l
0.65
26
266
14
93
1.51
0.69
35.9
45.4
7.18
7.10
ug/l
0.05
14
83
36
453
0.79
0.69
2.7
3.7
87.85
3302.25
u/ml
0.84
30
390
32
248
1.30
0.69
1.4
2.0
4.49
5.19
mmol/24h
0.64
26
225
61
723
0.84
0.67
1.4
1.6
—
—
—
0
0
7
43
1.63
0.67
1.3
1.2
—
—
—
0
0
78
905
0.86
0.66
1.1
1.1
—
—
—
0
0
183
2007
0.90
0.66
1.8
1.9
—
—
—
0
0
5
28
1.79
0.66
1.4
3.5
—
—
—
0
0
18
129
1.40
0.63
2.2
1.7
55.00
58.00
%
0.12
12
89
17
121
1.41
0.62
3.2
1.7
12.05
23.91
umol/l
4.38
17
113
387
3655
1.07
0.62
3.9
3.5
0.00
0.20
—
7
30
139
1253
1.12
0.61
1.4
1.5
24.08
22.07
iu/l
0.34
118
1033
0
22
0.00
0.59
0.0
2.7
—
3586.00
—
0
22
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
12
174
0.69
0.59
1.1
1.2
—
—
—
0
0
295
2769
1.08
0.56
1.3
1.3
9.42
10.05
u/ml
0.06
103
1135
11
73
1.51
0.56
1.1
1.5
0.12
2.00
u/ml
2.76
11
73
12
171
0.70
0.54
3.6
4.8
167.62
53.13
u/ml
—
6
56
54
459
1.18
0.54
1.2
1.2
—
—
—
0
0
281
2989
0.93
0.53
2.0
1.9
—
—
—
0
0
48
405
1.19
0.53
2.2
3.1
5.62
6.91
umol/l
0.44
40
308
6
39
1.54
0.53
1.2
1.0
6.21
6.56
mg/g
—
6
39
23
178
1.30
0.53
1.3
1.3
—
—
—
0
0
23
179
1.29
0.51
1.3
1.3
8.73
6.38
g/l
1.10
17
135
23
179
1.29
0.51
1.3
1.3
0.36
0.40
g/l
0.36
17
133
23
179
1.29
0.51
1.3
1.3
2.89
2.87
g/l
0.02
17
133
318
3007
1.07
0.50
1.3
1.3
24.76
25.10
iu/ml
0.02
99
864
492
5123
0.95
0.49
1.6
1.7
—
—
—
0
0
19
145
1.31
0.48
3.0
2.2
33.53
32.60
pg
0.55
19
145
372
3545
1.06
0.47
2.6
2.7
319.45
332.06
umol/l
1.59
325
3226
21
164
1.28
0.46
1.1
1.3
0.17
0.29
nmol/l
0.46
15
121
5
31
1.61
0.43
1.0
1.1
0.25
2.07
u/ml
—
5
21
160
1486
1.08
0.42
4.6
4.1
32.52
31.37
%
0.62
116
1075
74
827
0.89
0.42
1.4
1.3
282.15
225.11
miu/ml
0.74
36
409
12
87
1.38
0.42
2.4
1.6
37.29
32.78
%
—
7
55
8
57
1.41
0.42
1.1
1.4
29.13
28.26
s
—
8
57
47
407
1.16
0.41
1.1
1.1
0.13
0.29
u/ml
0.96
16
149
83
919
0.90
0.41
1.4
1.6
61.47
60.38
ug/l
0.08
69
780
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
8
61
1.31
0.39
1.0
1.1
43.63
41.48
iu/ml
—
8
61
7
104
0.67
0.39
1.1
1.1
—
1.31
—
0
17
65
579
1.13
0.39
1.1
1.1
4.88
6.27
u/ml
0.31
32
356
9
67
1.34
0.38
1.3
2.5
—
—
—
0
0
9
67
1.34
0.38
1.3
1.4
—
—
—
0
0
141
1312
1.08
0.37
1.4
1.3
143.64
236.38
u/ml
1.41
122
1222
23
189
1.22
0.36
1.0
1.3
0.94
3.71
u/ml
—
6
74
65
584
1.12
0.35
1.3
1.2
—
—
—
0
0
36
310
1.16
0.35
1.7
2.1
—
19.33
—
0
6
86
785
1.10
0.35
1.4
1.6
8.29
8.44
u/l
0.04
69
608
14
108
1.30
0.35
2.0
3.3
29.43
27.22
umol/l
0.59
14
99
29
246
1.18
0.34
1.3
1.6
—
—
—
0
0
29
246
1.18
0.34
1.3
1.6
—
—
—
0
0
29
246
1.18
0.34
1.3
1.6
—
—
—
0
0
29
246
1.18
0.34
1.3
1.6
—
—
—
0
0
47
415
1.14
0.34
1.4
1.6
—
—
—
0
0
18
145
1.24
0.33
1.1
1.4
1.81
1.49
nmol/l
0.82
18
133
6
46
1.31
0.33
2.7
2.3
11.95
1.97
ug/l
—
6
38
6
90
0.67
0.32
1.3
1.1
111.67
199.95
iu/ml
—
6
90
31
266
1.17
0.32
5.7
4.0
4.25
4.06
e9/l
0.15
31
266
25
295
0.85
0.32
1.3
1.1
—
—
—
0
0
17
137
1.24
0.32
3.8
2.2
23.08
31.98
mg/l
0.47
12
89
20
241
0.83
0.31
1.0
1.1
—
—
—
0
0
14
110
1.27
0.31
1.1
1.2
—
—
—
0
0
17
138
1.23
0.30
1.2
1.2
—
—
—
0
0
133
1251
1.07
0.29
3.8
3.5
—
—
—
0
0
17
205
0.83
0.28
1.2
1.1
21.10
17.07
u/ml
—
8
78
134
1419
0.94
0.27
2.6
2.3
11.13
12.67
nmol/l
1.34
117
1312
42
468
0.89
0.26
1.1
1.1
—
—
—
0
0
42
468
0.89
0.26
1.1
1.1
—
—
—
0
0
44
395
1.12
0.26
1.5
1.6
108.89
139.33
au/ml
—
9
126
34
300
1.14
0.26
1.5
1.7
0.74
0.77
g/l
0.07
25
241
13
104
1.25
0.26
1.1
1.1
1662.08
1528.81
miu/ml
0.17
13
104
29
253
1.15
0.26
1.2
1.2
—
—
—
0
0
47
424
1.11
0.26
1.1
1.1
4.65
6.87
u/ml
0.28
23
204
26
225
1.16
0.26
1.2
1.3
—
—
—
0
0
61
561
1.09
0.24
1.1
1.1
0.37
1.18
u/ml
1.94
29
284
16
134
1.20
0.23
1.1
1.1
119.75
110.74
pmol/l
0.26
16
134
84
788
1.07
0.21
1.0
1.1
—
—
—
0
0
5
42
1.19
0.21
1.0
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
162.09
—
0
11
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
595
6061
0.97
0.21
2.0
1.9
1.44
1.37
mmol/l
0.98
519
5332
0
12
0.00
0.21
0.0
1.6
—
11.00
—
0
7
49
450
1.09
0.21
1.1
1.1
4.12
5.91
u/ml
0.22
29
242
0
13
0.00
0.21
0.0
10.5
—
70.13
—
0
8
1367
13766
0.97
0.20
4.7
4.2
5.78
5.76
mmol/l
0.18
1281
12899
6
48
1.25
0.20
1.5
1.1
—
—
—
0
0
11
133
0.83
0.19
1.0
1.6
9.62
11.45
umol/l
0.44
11
122
6
51
1.18
0.19
1.2
2.0
—
—
—
0
0
6
52
1.15
0.19
1.0
1.5
16.33
18.06
umol/l
—
6
44
37
405
0.91
0.18
1.1
1.1
12.81
15.01
au/ml
—
7
103
13
109
1.19
0.18
1.2
1.2
—
—
—
0
0
7
61
1.15
0.17
1.0
1.6
0.00
0.05
estimate
—
7
61
37
339
1.09
0.17
1.3
1.2
—
—
—
0
0
41
378
1.09
0.17
5.1
3.6
58.02
56.69
%
0.24
41
378
13
111
1.17
0.15
2.2
1.5
0.48
0.50
e9/l
0.07
13
111
255
2489
1.03
0.14
2.1
2.9
122.51
107.01
ug/g
0.28
200
2015
17
151
1.13
0.13
2.8
3.2
—
—
—
0
0
17
190
0.89
0.13
1.2
1.2
—
—
—
0
0
41
437
0.94
0.12
1.3
1.5
0.33
0.43
nmol/l
0.33
33
355
12
137
0.88
0.12
1.0
1.0
—
—
—
0
0
108
1117
0.96
0.11
4.4
4.5
14.75
21.07
ug/l
0.27
87
889
66
631
1.05
0.11
1.7
1.7
10.49
7.91
u/ml
0.22
13
162
30
322
0.93
0.11
1.2
1.2
—
—
—
0
0
14
157
0.89
0.11
1.1
1.1
—
—
—
0
0
40
378
1.06
0.10
1.9
2.5
—
—
—
0
0
58
556
1.04
0.09
1.2
1.1
2.46
2.03
u/ml
0.09
30
317
38
360
1.06
0.09
2.7
2.4
1.10
0.83
nmol/l
1.19
33
312
6
56
1.07
0.08
1.3
2.7
—
—
—
0
0
12
107
1.12
0.08
1.2
1.1
—
—
—
0
0
7
66
1.06
0.08
4.4
4.0
—
—
—
0
0
6
70
0.86
0.07
4.2
2.8
41.67
44.13
%
—
6
70
6
70
0.86
0.07
8.3
5.7
12.67
8.33
%
—
6
70
19
176
1.08
0.07
2.0
2.2
—
—
—
0
0
16
147
1.09
0.07
1.2
1.2
—
—
—
0
0
9
85
1.06
0.07
1.4
1.1
—
—
—
0
0
57
551
1.04
0.07
1.2
1.1
—
—
—
0
0
33
345
0.96
0.06
2.0
1.8
—
—
—
0
0
840
8360
1.01
0.06
3.4
3.3
113.34
94.48
ug/l
1.02
795
7974
65
632
1.03
0.06
1.2
1.2
2.33
2.60
u/ml
0.09
34
363
11
121
0.91
0.06
1.2
1.1
—
—
—
0
0
466
4633
1.01
0.04
2.4
2.2
—
—
—
0
0
17
160
1.06
0.04
1.2
1.4
—
—
—
0
0
12
129
0.93
0.03
1.2
1.2
—
—
—
0
0
16
152
1.05
0.02
1.9
3.3
160.70
205.37
e6/l
—
10
119
88
869
1.01
0.02
1.4
1.4
—
—
—
0
0
11
103
1.07
0.02
1.5
1.6
—
—
—
0
0
165
1641
1.01
0.01
1.3
1.4
—
—
—
0
0
32
327
0.98
0.01
1.9
1.7
7646.61
11475.58
e6/l
0.59
23
231
16
166
0.96
0.00
1.3
1.6
601.68
811.33
pmol/l
—
5
22
10
105
0.95
0.00
1.4
1.4
66.10
75.72
umol/l
—
10
105
10
105
0.95
0.00
2.3
2.8
43.00
44.60
%
—
5
54
15
151
0.99
0.00
2.1
3.2
330.44
512.39
e6/l
—
9
113
42
415
1.01
0.00
9.7
9.3
—
—
—
0
0
11
106
1.04
0.00
3.1
2.6
—
—
—
0
0
26
264
0.98
0.00
2.7
2.4
73.53
113.38
ug/min
0.31
15
166
12
122
0.98
0.00
1.9
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
94
0.96
-0.00
1.0
1.0
7.35
8.95
mu/l
—
9
85
7
77
0.91
-0.00
1.1
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
20
200
1.00
-0.00
3.4
4.2
5100.70
308.00
u/ml
0.45
20
186
48
480
1.00
-0.00
1.3
1.5
265.38
222.01
u/ml
0.39
24
277
0
7
0.00
-0.00
0.0
7.0
—
—
—
0
0
6
66
0.91
-0.00
1.2
1.3
—
96.00
—
0
47
0
6
0.00
-0.00
0.0
1.0
—
3.46
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.2
—
0.55
—
0
6
6
63
0.95
-0.00
1.0
1.0
—
—
—
0
0
7
74
0.95
-0.00
1.1
1.3
171.79
176.88
mmol/24h
—
7
74
6
62
0.97
-0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
2.02
—
0
5
9
94
0.96
-0.00
2.8
1.4
8.67
6.98
u/l
—
9
79
0
9
0.00
-0.00
0.0
2.4
—
195.33
—
0
9
0
5
0.00
-0.00
0.0
1.6
—
1300.40
—
0
5
0
7
0.00
-0.00
0.0
2.0
—
0.57
—
0
7

Mortality – FinRegistry

↥

Association

Association between endpoint GE and mortality.

Females

Parameter HR [95% CI] p-value
GE 3.087 [2.71, 3.52] < 0.001
Birth year 0.994 [0.99, 1.0] 0.17

During the follow-up period (1.1.1998 — 31.12.2019), 687 out of 6796 females with GE died.

Males

Parameter HR [95% CI] p-value
GE 2.745 [2.43, 3.11] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 870 out of 5793 males with GE died.

Mortality risk

Mortality risk for people of age

years, who have GE.

N-year risk Females Males
1 0.297% 0.461%
5 1.675% 3.273%
10 4.035% 7.686%
15 8.089% 14.45%
20 13.76% 22.713%

Relationships between endpoints

↥

Index endpoint: GE – Generalized epilepsy

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data